#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
CRP.3000518.AP009048.4153663_4154296.461	CRP.3000518.AP009048.4153663_4154296.461	1	0	539	862	CRP	633	633	99.53	CRP.l15.c30.ctg.1	1325	34.9	0	.	p	.	0	K29T	NONSYN	85	87	AAG	350	352	ACG	45;46;46	A;C;G	45;46;46	.	CRP is a global regulator that represses MdtEF multidrug efflux pump expression.;CRP
Enterobacter_aerogenes_omp36.3003385.AF335467.36_1164.2109	Enterobacter_aerogenes_omp36.3003385.AF335467.36_1164.2109	1	1	528	64	Enterobacter_aerogenes_omp36	1128	81	96.3	Enterobacter_aerogenes_omp36.l15.c4.ctg.4	93	4.1	0	.	p	.	0	K354Q	NONSYN	1060	1062	AAG	75	77	CAG	1;1;1	C;A;G	1;1;1	.	Enterobacter aerogenes omp36 mutants
Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	1	1	167	2922	Escherichia_coli_EF_Tu	1230	1209	99.83	Escherichia_coli_EF_Tu.l15.c30.ctg.1	1473	96.6	1	SNP	p	R234F	1	.	.	700	702	TTC	964	966	TTC	103;104;103	T;T;C	103;103;102	Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356:1:1:R234F:.:Sequence variants of Escherichia coli elongation factor Tu that confer resistance to Pulvomycin	Escherichia coli EF-Tu mutants conferring resistance to Pulvomycin
Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	1	1	167	2922	Escherichia_coli_EF_Tu	1230	1209	99.83	Escherichia_coli_EF_Tu.l15.c30.ctg.1	1473	96.6	1	SNP	p	R334C	0	.	.	1000	1002	CGT	1264	1266	CGT	118;118;119	C;G;T	113;117;117	Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356:1:1:R334C:.:Sequence variants of Escherichia coli elongation factor Tu that confer resistance to Pulvomycin	Escherichia coli EF-Tu mutants conferring resistance to Pulvomycin
Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	1	1	167	2922	Escherichia_coli_EF_Tu	1230	1209	99.83	Escherichia_coli_EF_Tu.l15.c30.ctg.1	1473	96.6	0	HET	.	.	.	T999C	.	999	999	T	1263	1263	T	109	T,C	68,39	.	Escherichia coli EF-Tu mutants conferring resistance to Pulvomycin
Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	1	1	167	2922	Escherichia_coli_EF_Tu	1230	1209	99.83	Escherichia_coli_EF_Tu.l15.c30.ctg.1	1473	96.6	0	HET	.	.	.	T180C	.	180	180	T	444	444	T	78	T,C	39,32	.	Escherichia coli EF-Tu mutants conferring resistance to Pulvomycin
Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	1	1	167	2922	Escherichia_coli_EF_Tu	1230	1209	99.83	Escherichia_coli_EF_Tu.l15.c30.ctg.1	1473	96.6	0	HET	.	.	.	C255T	.	255	255	C	519	519	C	106	C,T	60,45	.	Escherichia coli EF-Tu mutants conferring resistance to Pulvomycin
Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	1	1	167	2922	Escherichia_coli_EF_Tu	1230	1209	99.83	Escherichia_coli_EF_Tu.l15.c30.ctg.1	1473	96.6	0	HET	.	.	.	C996A	.	996	996	C	1260	1260	C	108	C,A	69,38	.	Escherichia coli EF-Tu mutants conferring resistance to Pulvomycin
Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	1	1	167	2922	Escherichia_coli_EF_Tu	1230	72	100.0	Escherichia_coli_EF_Tu.l15.c30.ctg.2	146	15.6	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Escherichia coli EF-Tu mutants conferring resistance to Pulvomycin
Escherichia_coli_mutant.3003889.HG738867.2233288_2234647.3666	Escherichia_coli_mutant.3003889.HG738867.2233288_2234647.3666	1	1	539	1216	Escherichia_coli_mutant_1	1359	1359	99.85	Escherichia_coli_mutant_1.l15.c30.ctg.1	1884	34.5	1	SNP	p	E448K	1	E448K	NONSYN	1342	1344	GAA	1597	1599	AAA	20;20;20	A;A;A	20;20;20	Escherichia_coli_mutant.3003889.HG738867.2233288_2234647.3666:1:1:E448K:.:Mutations to the active importer GlpT, which is involved with the uptake of many phosphorylated sugars, confer resistance to fosfomycin by reducing import of the drug into the bacteria.	Escherichia coli mutant GlpT conferring resistance to fosfomycin
Escherichia_coli_mutant.3003890.HG738867.2934266_2935658.3667	Escherichia_coli_mutant.3003890.HG738867.2934266_2935658.3667	1	1	27	1502	Escherichia_coli_mutant	1392	1392	99.43	Escherichia_coli_mutant.l15.c30.ctg.1	1837	43.4	1	SNP	p	E350Q	0	.	.	1048	1050	GAA	1319	1321	GAA	64;62;61	G;A;A	64;62;60	Escherichia_coli_mutant.3003890.HG738867.2934266_2935658.3667:1:1:E350Q:.:Mutations to the active importer UhpT, which is involved with the uptake of many phosphorylated sugars, confer resistance to fosfomycin by reducing import of the drug into the bacteria.	Escherichia coli mutant UhpT conferring resistance to fosfomycin
H_NS.3000676.NC_002695.1737553_1737967.218	H_NS.3000676.NC_002695.1737553_1737967.218	1	0	27	294	H_NS	414	414	99.03	H_NS.l15.c17.ctg.1	634	22.0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	H-NS;H-NS is a histone-like protein involved in global gene regulation in Gram-negative bacteria. It is a repressor of the membrane fusion protein genes acrE, mdtE, and emrK as well as nearby genes of many RND-type multidrug exporters.
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	640	4248	Pasteurella_multocida_16S	1551	159	94.34	Pasteurella_multocida_16S.l15.c30.ctg.2	159	101.8	0	.	n	.	0	T289C	SNP	289	289	T	5	5	C	13	C	2	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	640	4248	Pasteurella_multocida_16S	1551	159	94.34	Pasteurella_multocida_16S.l15.c30.ctg.2	159	101.8	0	.	n	.	0	A303G	SNP	303	303	A	19	19	G	70	G	57	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	640	4248	Pasteurella_multocida_16S	1551	159	94.34	Pasteurella_multocida_16S.l15.c30.ctg.2	159	101.8	0	.	n	.	0	G375A	SNP	375	375	G	91	91	A	98	A,G	96,1	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	640	4248	Pasteurella_multocida_16S	1551	159	94.34	Pasteurella_multocida_16S.l15.c30.ctg.2	159	101.8	0	.	n	.	0	G383C	SNP	383	383	G	99	99	C	52	C	51	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	640	4248	Pasteurella_multocida_16S	1551	159	94.34	Pasteurella_multocida_16S.l15.c30.ctg.2	159	101.8	0	.	n	.	0	G385C	SNP	385	385	G	101	101	C	36	C	35	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	640	4248	Pasteurella_multocida_16S	1551	159	94.34	Pasteurella_multocida_16S.l15.c30.ctg.2	159	101.8	0	.	n	.	0	C388G	SNP	388	388	C	104	104	G	19	G	18	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	640	4248	Pasteurella_multocida_16S	1551	159	94.34	Pasteurella_multocida_16S.l15.c30.ctg.2	159	101.8	0	.	n	.	0	C394T	SNP	394	394	C	110	110	T	6	T	6	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	640	4248	Pasteurella_multocida_16S	1551	159	94.34	Pasteurella_multocida_16S.l15.c30.ctg.2	159	101.8	0	.	n	.	0	A411T	SNP	411	411	A	127	127	T	4	T	4	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	640	4248	Pasteurella_multocida_16S	1551	159	94.34	Pasteurella_multocida_16S.l15.c30.ctg.2	159	101.8	0	.	n	.	0	T439A	SNP	439	439	T	155	155	A	4	A	4	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	640	4248	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l15.c30.ctg.3	779	139.5	0	.	n	.	0	T1041G	SNP	1041	1041	T	16	16	G	164	G	124	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	640	4248	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l15.c30.ctg.3	779	139.5	0	.	n	.	0	A1042T	SNP	1042	1042	A	17	17	T	176	T	136	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	640	4248	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l15.c30.ctg.3	779	139.5	0	.	n	.	0	A1136G	SNP	1136	1136	A	111	111	G	255	G	254	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	640	4248	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l15.c30.ctg.3	779	139.5	0	.	n	.	0	T1138C	SNP	1138	1138	T	113	113	C	235	C	235	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	640	4248	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l15.c30.ctg.3	779	139.5	0	.	n	.	0	T1142C	SNP	1142	1142	T	117	117	C	208	C	208	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	640	4248	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l15.c30.ctg.3	779	139.5	0	.	n	.	0	C1170T	SNP	1170	1170	C	145	145	T	203	T,G	201,1	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	640	4248	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l15.c30.ctg.3	779	139.5	0	.	n	.	0	T1220C	SNP	1220	1220	T	195	195	C	186	C	185	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	640	4248	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l15.c30.ctg.3	779	139.5	0	.	n	.	0	T1245C	SNP	1245	1245	T	220	220	C	147	C	145	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	640	4248	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l15.c30.ctg.3	779	139.5	0	.	n	.	0	G1253A	SNP	1253	1253	G	228	228	A	151	A,G	150,1	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	640	4248	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l15.c30.ctg.3	779	139.5	0	.	n	.	0	G1256A	SNP	1256	1256	G	231	231	A	149	A	149	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	640	4248	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l15.c30.ctg.3	779	139.5	0	.	n	.	0	C1258A	SNP	1258	1258	C	233	233	A	146	A	146	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	640	4248	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l15.c30.ctg.3	779	139.5	0	.	n	.	0	G1266T	SNP	1266	1266	G	241	241	T	144	T	143	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	640	4248	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l15.c30.ctg.3	779	139.5	0	.	n	.	0	T1267C	SNP	1267	1267	T	242	242	C	143	C	143	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	640	4248	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l15.c30.ctg.3	779	139.5	0	.	n	.	0	T1275C	SNP	1275	1275	T	250	250	C	136	C	134	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	640	4248	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l15.c30.ctg.3	779	139.5	0	.	n	.	0	G1276A	SNP	1276	1276	G	251	251	A	134	A	134	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	640	4248	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l15.c30.ctg.3	779	139.5	0	.	n	.	0	A1281G	SNP	1281	1281	A	256	256	G	129	G,T	128,1	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	640	4248	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l15.c30.ctg.3	779	139.5	0	.	n	.	0	T1283C	SNP	1283	1283	T	258	258	C	130	C	130	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	640	4248	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l15.c30.ctg.3	779	139.5	0	.	n	.	0	G1288T	SNP	1288	1288	G	263	263	T	144	T	144	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	640	4248	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l15.c30.ctg.3	779	139.5	0	.	n	.	0	A1296G	SNP	1296	1296	A	271	271	G	196	G	195	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	640	4248	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l15.c30.ctg.3	779	139.5	0	.	n	.	0	T1299G	SNP	1299	1299	T	274	274	G	214	G	214	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	640	4248	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l15.c30.ctg.3	779	139.5	0	.	n	.	0	A1300T	SNP	1300	1300	A	275	275	T	219	T	217	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	640	4248	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l15.c30.ctg.3	779	139.5	0	.	n	.	0	C1356T	SNP	1356	1356	C	331	331	T	185	T	181	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	640	4248	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l15.c30.ctg.3	779	139.5	0	.	n	.	0	A1358G	SNP	1358	1358	A	333	333	G	174	G	174	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	640	4248	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l15.c30.ctg.3	779	139.5	0	.	n	.	0	T1368C	SNP	1368	1368	T	343	343	C	149	C	148	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	640	4248	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l15.c30.ctg.3	779	139.5	0	.	n	.	0	G1370A	SNP	1370	1370	G	345	345	A	138	A	138	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	640	4248	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l15.c30.ctg.3	779	139.5	0	.	n	.	0	C1406.	DEL	1406	1406	C	380	380	C	82	C	81	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	640	4248	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l15.c30.ctg.3	779	139.5	0	.	n	.	0	.1409C	INS	1409	1409	T	384	384	C	78	C	78	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	640	4248	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l15.c30.ctg.3	779	139.5	0	.	n	.	0	C1431A	SNP	1431	1431	C	406	406	A	22	A	22	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	640	4248	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l15.c30.ctg.3	779	139.5	0	.	n	.	0	C1432A	SNP	1432	1432	C	407	407	A	22	A	22	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	640	4248	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l15.c30.ctg.3	779	139.5	0	.	n	.	0	A1441G	SNP	1441	1441	A	416	416	G	21	G	21	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	640	4248	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l15.c30.ctg.3	779	139.5	0	.	n	.	0	T1464C	SNP	1464	1464	T	439	439	C	38	C	38	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	640	4248	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l15.c30.ctg.3	779	139.5	0	.	n	.	0	G1473T	SNP	1473	1473	G	448	448	T	108	T	108	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	640	4248	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l15.c30.ctg.3	779	139.5	0	.	n	.	0	A1475G	SNP	1475	1475	A	450	450	G	124	G	124	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	640	4248	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l15.c30.ctg.3	779	139.5	0	.	n	.	0	A1548T	SNP	1548	1548	A	523	523	T	94	T	94	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	640	4248	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l15.c30.ctg.3	779	139.5	1	SNP	n	C1194G	0	.	.	1194	1194	C	169	169	C	208	C	208	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252:0:0:C1194G:.:Point mutations in the helix 34 region of 16S rRNA of Pasteurella multocida can confer resistance to spectinomycin	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	640	4248	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l15.c30.ctg.3	779	139.5	0	HET	.	.	.	C1040T	.	1040	1040	T	15	15	C	155	C,T	72,44	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
PmrB.3003583.NC_007779.4336858_4337950.2119	PmrB.3003583.NC_007779.4336858_4337950.2119	1	0	539	1228	PmrB_1	1092	1092	99.08	PmrB_1.l6.c4.ctg.1	1615	40.7	0	.	p	.	0	H2R	NONSYN	4	6	CAT	248	250	CGT	42;43;44	C;G;T	42;43;44	.	PmrB;Histidine protein kinase sensor Lipid A modification gene; part of a two-component system involved in polymyxin resistance that senses high extracellular Fe(2+)
PmrB.3003583.NC_007779.4336858_4337950.2119	PmrB.3003583.NC_007779.4336858_4337950.2119	1	0	539	1228	PmrB_1	1092	1092	99.08	PmrB_1.l6.c4.ctg.1	1615	40.7	0	.	p	.	0	V30I	NONSYN	88	90	GTC	332	334	ATC	44;45;45	A;T;C	44;45;45	.	PmrB;Histidine protein kinase sensor Lipid A modification gene; part of a two-component system involved in polymyxin resistance that senses high extracellular Fe(2+)
PmrB.3003583.NC_007779.4336858_4337950.2119	PmrB.3003583.NC_007779.4336858_4337950.2119	1	0	539	1228	PmrB_1	1092	1092	99.08	PmrB_1.l6.c4.ctg.1	1615	40.7	0	.	p	.	0	D283G	NONSYN	847	849	GAC	1091	1093	GGC	49;47;47	G;G;C	49;47;47	.	PmrB;Histidine protein kinase sensor Lipid A modification gene; part of a two-component system involved in polymyxin resistance that senses high extracellular Fe(2+)
PmrC.3003576.AP009048.4338624_4340268.2117	PmrC.3003576.AP009048.4338624_4340268.2117	1	0	539	1692	PmrC	1644	1644	99.15	PmrC.l6.c4.ctg.1	2175	41.5	0	.	p	.	0	R8S	NONSYN	22	24	AGA	336	338	AGC	23;23;25	A;G;C	22;23;25	.	PmrC;PmrC mediates the modification of Lipid A by the addition of 4-amino-4-deoxy-L-arabinose (L-Ara4N) and phosphoethanolamine, resulting in a less negative cell membrane and decreased binding of polymyxin B.
PmrC.3003576.AP009048.4338624_4340268.2117	PmrC.3003576.AP009048.4338624_4340268.2117	1	0	539	1692	PmrC	1644	1644	99.15	PmrC.l6.c4.ctg.1	2175	41.5	0	.	p	.	0	I142L	NONSYN	424	426	ATA	738	740	CTA	37;37;39	C;T,A;A	36;36,1;39	.	PmrC;PmrC mediates the modification of Lipid A by the addition of 4-amino-4-deoxy-L-arabinose (L-Ara4N) and phosphoethanolamine, resulting in a less negative cell membrane and decreased binding of polymyxin B.
PmrC.3003576.AP009048.4338624_4340268.2117	PmrC.3003576.AP009048.4338624_4340268.2117	1	0	539	1692	PmrC	1644	1644	99.15	PmrC.l6.c4.ctg.1	2175	41.5	0	.	p	.	0	R315Q	NONSYN	943	945	CGA	1257	1259	CAA	62;61;61	C;A;A	62;61;61	.	PmrC;PmrC mediates the modification of Lipid A by the addition of 4-amino-4-deoxy-L-arabinose (L-Ara4N) and phosphoethanolamine, resulting in a less negative cell membrane and decreased binding of polymyxin B.
PmrC.3003576.AP009048.4338624_4340268.2117	PmrC.3003576.AP009048.4338624_4340268.2117	1	0	539	1692	PmrC	1644	1644	99.15	PmrC.l6.c4.ctg.1	2175	41.5	0	.	p	.	0	D348G	NONSYN	1042	1044	GAT	1356	1358	GGT	42;41;39	G;G;T	41;41;38	.	PmrC;PmrC mediates the modification of Lipid A by the addition of 4-amino-4-deoxy-L-arabinose (L-Ara4N) and phosphoethanolamine, resulting in a less negative cell membrane and decreased binding of polymyxin B.
PmrC.3003576.AP009048.4338624_4340268.2117	PmrC.3003576.AP009048.4338624_4340268.2117	1	0	539	1692	PmrC	1644	1644	99.15	PmrC.l6.c4.ctg.1	2175	41.5	0	.	p	.	0	I538V	NONSYN	1612	1614	ATT	1926	1928	GTT	29;27;25	G,A;T;T	28,1;27;25	.	PmrC;PmrC mediates the modification of Lipid A by the addition of 4-amino-4-deoxy-L-arabinose (L-Ara4N) and phosphoethanolamine, resulting in a less negative cell membrane and decreased binding of polymyxin B.
PmrE.3003577.U00096.2098446_2099613.2116	PmrE.3003577.U00096.2098446_2099613.2116	1	0	539	782	PmrE	1167	1167	96.83	PmrE.l6.c30.ctg.1	1666	25.1	0	.	p	.	0	A125E	NONSYN	373	375	GCA	591	593	GAA	27;28;28	G;A;A	27;28;28	.	PmrE is required for the synthesis and transfer of 4-amino-4-deoxy-L-arabinose (Ara4N) to Lipid A, which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin;PmrE
PmrE.3003577.U00096.2098446_2099613.2116	PmrE.3003577.U00096.2098446_2099613.2116	1	0	539	782	PmrE	1167	1167	96.83	PmrE.l6.c30.ctg.1	1666	25.1	0	.	p	.	0	M185T	NONSYN	553	555	ATG	771	773	ACC	18;18;18	A;C;C	17;18;18	.	PmrE is required for the synthesis and transfer of 4-amino-4-deoxy-L-arabinose (Ara4N) to Lipid A, which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin;PmrE
PmrE.3003577.U00096.2098446_2099613.2116	PmrE.3003577.U00096.2098446_2099613.2116	1	0	539	782	PmrE	1167	1167	96.83	PmrE.l6.c30.ctg.1	1666	25.1	0	.	p	.	0	S225T	NONSYN	673	675	TCC	891	893	ACT	17;16;17	A;C;T	16;16;17	.	PmrE is required for the synthesis and transfer of 4-amino-4-deoxy-L-arabinose (Ara4N) to Lipid A, which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin;PmrE
PmrE.3003577.U00096.2098446_2099613.2116	PmrE.3003577.U00096.2098446_2099613.2116	1	0	539	782	PmrE	1167	1167	96.83	PmrE.l6.c30.ctg.1	1666	25.1	0	.	p	.	0	T355I	NONSYN	1063	1065	ACC	1281	1283	ATC	16;17;16	A;T;C	16;17;16	.	PmrE is required for the synthesis and transfer of 4-amino-4-deoxy-L-arabinose (Ara4N) to Lipid A, which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin;PmrE
PmrF.3003578.U00096.2367070_2368039.2115	PmrF.3003578.U00096.2367070_2368039.2115	1	0	27	1020	PmrF	969	969	99.38	PmrF.l15.c30.ctg.1	1512	35.8	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	PmrF is required for the synthesis and transfer of 4-amino-4-deoxy-L-arabinose (Ara4N) to Lipid A, which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin;PmrF
TEM_187.3001047.HM246246.211_1069.1956	TEM_187.3001047.HM246246.211_1069.1956	1	0	512	90	TEM_1+	858	175	98.86	TEM_1+.l15.c4.ctg.1	175	4.6	0	.	p	.	0	F19L	NONSYN	55	57	TTT	44	46	CTT	6;6;6	C;T;T	6;6;6	.	TEM-187 is an extended-spectrum beta-lactamase found in P. mirabilis;TEM-187
TEM_187.3001047.HM246246.211_1069.1956	TEM_187.3001047.HM246246.211_1069.1956	1	0	512	90	TEM_1+	858	336	99.4	TEM_1+.l15.c4.ctg.2	338	5.3	0	.	p	.	0	H162R	NONSYN	484	486	CAT	106	108	CGT	2;2;2	C;G;T	2;2;2	.	TEM-187 is an extended-spectrum beta-lactamase found in P. mirabilis;TEM-187
TEM_187.3001047.HM246246.211_1069.1956	TEM_187.3001047.HM246246.211_1069.1956	1	0	512	90	TEM_1+	858	77	100.0	TEM_1+.l15.c4.ctg.3	77	5.7	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	TEM-187 is an extended-spectrum beta-lactamase found in P. mirabilis;TEM-187
aada1.manually_added_NC_007384_WP_001206315.1_4110458_4111246	aada1.manually_added_NC_007384_WP_001206315.1_4110458_4111246	1	0	27	920	aad-	789	789	100.0	aad-.l15.c4.ctg.1	1461	33.4	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Original ref seq: NC_007384.1 Shigella sonnei Ss046, complete genome
acrD.3000491.NC_007779.2586250_2589364.664	acrD.3000491.NC_007779.2586250_2589364.664	1	0	539	3066	acrD	3114	3114	99.07	acrD.l15.c4.ctg.1	3630	45.2	0	.	p	.	0	T85I	NONSYN	253	255	ACC	522	524	ATC	40;41;41	A;T;C	40;41;41	.	AcrD is an aminoglycoside efflux pump expressed in E. coli. Its expression can be induced by indole, and is regulated by baeRS and cpxAR.;acrD
acrD.3000491.NC_007779.2586250_2589364.664	acrD.3000491.NC_007779.2586250_2589364.664	1	0	539	3066	acrD	3114	3114	99.07	acrD.l15.c4.ctg.1	3630	45.2	0	.	p	.	0	V416I	NONSYN	1246	1248	GTC	1515	1517	ATC	47;49;51	A;T;C	47;48;51	.	AcrD is an aminoglycoside efflux pump expressed in E. coli. Its expression can be induced by indole, and is regulated by baeRS and cpxAR.;acrD
acrD.3000491.NC_007779.2586250_2589364.664	acrD.3000491.NC_007779.2586250_2589364.664	1	0	539	3066	acrD	3114	3114	99.07	acrD.l15.c4.ctg.1	3630	45.2	0	.	p	.	0	Q656K	NONSYN	1966	1968	CAA	2235	2237	AAG	33;34;34	A;A;G	33;34;34	.	AcrD is an aminoglycoside efflux pump expressed in E. coli. Its expression can be induced by indole, and is regulated by baeRS and cpxAR.;acrD
acrE.3000499.U00096.3413863_3415021.333	acrE.3000499.U00096.3413863_3415021.333	1	0	539	1202	acrE	1158	1158	98.79	acrE.l15.c30.ctg.1	1485	42.3	0	.	p	.	0	A22V	NONSYN	64	66	GCC	106	108	GTC	11;11;12	G;T;C	11;11;12	.	AcrE is a membrane fusion protein, similar to AcrA.;acrE
acrE.3000499.U00096.3413863_3415021.333	acrE.3000499.U00096.3413863_3415021.333	1	0	539	1202	acrE	1158	1158	98.79	acrE.l15.c30.ctg.1	1485	42.3	0	.	p	.	0	S269C	NONSYN	805	807	AGC	847	849	TGC	54;55;57	T;G;C	54;55;57	.	AcrE is a membrane fusion protein, similar to AcrA.;acrE
acrF.3000502.U00096.3415032_3418137.700	acrF.3000502.U00096.3415032_3418137.700	1	0	528	2804	acrF	3105	2598	98.04	acrF.l6.c30.ctg.1	3252	45.9	0	.	p	.	0	S46trunc	TRUNC	136	136	T	505	505	T	28	T	28	.	acrF;AcrF is a inner membrane transporter, similar to AcrB.
acrF.3000502.U00096.3415032_3418137.700	acrF.3000502.U00096.3415032_3418137.700	1	0	528	2804	acrF	3105	2598	98.04	acrF.l6.c30.ctg.1	3252	45.9	0	.	p	.	0	G148D	NONSYN	442	444	GGC	811	813	GAC	42;41;40	G;A;C	42;41;38	.	acrF;AcrF is a inner membrane transporter, similar to AcrB.
acrF.3000502.U00096.3415032_3418137.700	acrF.3000502.U00096.3415032_3418137.700	1	0	528	2804	acrF	3105	2598	98.04	acrF.l6.c30.ctg.1	3252	45.9	0	.	p	.	0	F240L	NONSYN	718	720	TTT	1087	1089	TTA	37;37;36	T;T;A	37;37;36	.	acrF;AcrF is a inner membrane transporter, similar to AcrB.
acrF.3000502.U00096.3415032_3418137.700	acrF.3000502.U00096.3415032_3418137.700	1	0	528	2804	acrF	3105	2598	98.04	acrF.l6.c30.ctg.1	3252	45.9	0	.	p	.	0	D301N	NONSYN	901	903	GAT	1270	1272	AAT	39;40;41	A;A;T	39;40;40	.	acrF;AcrF is a inner membrane transporter, similar to AcrB.
acrF.3000502.U00096.3415032_3418137.700	acrF.3000502.U00096.3415032_3418137.700	1	0	528	2804	acrF	3105	2598	98.04	acrF.l6.c30.ctg.1	3252	45.9	0	.	p	.	0	L563fs	FSHIFT	1687	1687	T	2057	2057	T	53	T	53	.	acrF;AcrF is a inner membrane transporter, similar to AcrB.
acrR.3003807.NC_000913.3.485760_486408.3575	acrR.3003807.NC_000913.3.485760_486408.3575	1	1	27	772	acrR_2	648	648	99.54	acrR_2.l15.c17.ctg.1	1335	30.7	1	SNP	p	R45C	0	.	.	133	135	CGC	465	467	CGC	48;52;51	C;G;C	48;52;51	acrR.3003807.NC_000913.3.485760_486408.3575:1:1:R45C:.:AcrR is a repressor of the AcrAB-TolC multidrug efflux complex. AcrR mutations result in high level antibiotic resistance. The mutations associated with this model are specific to E. coli.	Escherichia coli acrR mutants resulting in antibiotic resistance
acrS.3000656.U00096.3412802_3413465.551	acrS.3000656.U00096.3412802_3413465.551	1	0	539	690	acrS	663	663	98.64	acrS.l15.c4.ctg.1	1149	32.0	0	.	p	.	0	L34F	NONSYN	100	102	CTC	309	311	TTC	36;36;36	T;T;C	35;36;35	.	AcrS is a repressor of the AcrAB efflux complex and is associated with the expression of AcrEF. AcrS is believed to regulate a switch between AcrAB and AcrEF efflux.;acrS
acrS.3000656.U00096.3412802_3413465.551	acrS.3000656.U00096.3412802_3413465.551	1	0	539	690	acrS	663	663	98.64	acrS.l15.c4.ctg.1	1149	32.0	0	.	p	.	0	E122G	NONSYN	364	366	GAG	573	575	GGG	38;36;35	G,A;G;G	36,1;35;35	.	AcrS is a repressor of the AcrAB efflux complex and is associated with the expression of AcrEF. AcrS is believed to regulate a switch between AcrAB and AcrEF efflux.;acrS
adiY.3003828.NC_000913.3.4337167_4337929.3591	adiY.3003828.NC_000913.3.4337167_4337929.3591	1	0	539	840	adiY	762	762	99.61	adiY.l6.c4.ctg.1	1318	34.1	0	.	p	.	0	V136L	NONSYN	406	408	GTT	659	661	CTT	53;53;52	C;T;T	53;52;52	.	adiY is a DNA-binding transcriptional activator of the adi system. Implicated in arginine-dependent acid resistance in Escherichia coli.;adiY
alaS.3003830.NC_000913.3.2819380_2822011.3592	alaS.3003830.NC_000913.3.2819380_2822011.3592	1	0	539	2824	alaS	2631	2631	98.86	alaS.l15.c4.ctg.1	3226	46.9	0	.	p	.	0	T618A	NONSYN	1852	1854	ACA	2165	2167	GCA	63;64;67	G;C;A	63;64;67	.	alanyl-tRNA synthetase conferring resistance to novobiocin in Escherichia coli;aminocoumarin resistant alaS
alaS.3003830.NC_000913.3.2819380_2822011.3592	alaS.3003830.NC_000913.3.2819380_2822011.3592	1	0	539	2824	alaS	2631	2631	98.86	alaS.l15.c4.ctg.1	3226	46.9	0	.	p	.	0	A705T	NONSYN	2113	2115	GCC	2426	2428	ACC	59;61;58	A;C;C	56;60;58	.	alanyl-tRNA synthetase conferring resistance to novobiocin in Escherichia coli;aminocoumarin resistant alaS
alaS.3003830.NC_000913.3.2819380_2822011.3592	alaS.3003830.NC_000913.3.2819380_2822011.3592	1	0	539	2824	alaS	2631	2631	98.86	alaS.l15.c4.ctg.1	3226	46.9	0	.	p	.	0	V808A	NONSYN	2422	2424	GTC	2735	2737	GCC	31;31;30	G;C;C	31;28;28	.	alanyl-tRNA synthetase conferring resistance to novobiocin in Escherichia coli;aminocoumarin resistant alaS
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	539	1502	arnA_1	1983	1983	98.29	arnA_1.l15.c4.ctg.1	2495	32.2	0	.	p	.	0	G37A	NONSYN	109	111	GGT	358	360	GCT	9;10;11	G;C;T	9;10;11	.	arnA;arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	539	1502	arnA_1	1983	1983	98.29	arnA_1.l15.c4.ctg.1	2495	32.2	0	.	p	.	0	D77E	NONSYN	229	231	GAT	478	480	GAG	2;2;2	G;A;G	2;2;2	.	arnA;arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	539	1502	arnA_1	1983	1983	98.29	arnA_1.l15.c4.ctg.1	2495	32.2	0	.	p	.	0	Y89C	NONSYN	265	267	TAC	514	516	TGC	8;9;9	T;G;C	8;9;9	.	arnA;arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	539	1502	arnA_1	1983	1983	98.29	arnA_1.l15.c4.ctg.1	2495	32.2	0	.	p	.	0	I150V	NONSYN	448	450	ATT	697	699	GTT	17;18;20	G;T;T	17;17;20	.	arnA;arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	539	1502	arnA_1	1983	1983	98.29	arnA_1.l15.c4.ctg.1	2495	32.2	0	.	p	.	0	R200H	NONSYN	598	600	CGC	847	849	CAC	34;33;35	C;A;C	34;33;35	.	arnA;arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	539	1502	arnA_1	1983	1983	98.29	arnA_1.l15.c4.ctg.1	2495	32.2	0	.	p	.	0	T295M	NONSYN	883	885	ACG	1132	1134	ATG	52;52;52	A;T,A;G	52;51,1;52	.	arnA;arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	539	1502	arnA_1	1983	1983	98.29	arnA_1.l15.c4.ctg.1	2495	32.2	0	.	p	.	0	H627R	NONSYN	1879	1881	CAC	2128	2130	CGC	16;17;17	C;G;C	15;17;17	.	arnA;arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.
bacA.3002986.U00096.3203309_3204131.36	bacA.3002986.U00096.3203309_3204131.36	1	0	539	662	bacA	822	822	98.54	bacA.l15.c30.ctg.1	1338	26.3	0	.	p	.	0	S221T	NONSYN	661	663	AGC	938	940	ACC	14;14;15	A;C;C	14;14;15	.	bacA;bacA is a gene that recycles undecaprenyl pyrophosphate during cell wall biosynthesis which confers resistance to bacitracin
bacA.3002986.U00096.3203309_3204131.36	bacA.3002986.U00096.3203309_3204131.36	1	0	539	662	bacA	822	822	98.54	bacA.l15.c30.ctg.1	1338	26.3	0	.	p	.	0	P225S	NONSYN	673	675	CCG	950	952	TCG	13;14;14	T;C;G	13;14;14	.	bacA;bacA is a gene that recycles undecaprenyl pyrophosphate during cell wall biosynthesis which confers resistance to bacitracin
baeR.3000828.NC_007779.2166412_2167135.676	baeR.3000828.NC_007779.2166412_2167135.676	1	0	27	592	baeR	723	723	97.79	baeR.l15.c30.ctg.1	1252	25.4	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	baeR;BaeR is a response regulator that promotes the expression of MdtABC and AcrD efflux complexes.
baeS.3000829.AP009048.2165012_2166416.608	baeS.3000829.AP009048.2165012_2166416.608	1	0	539	1180	baeS	1404	1404	98.86	baeS.l15.c4.ctg.1	1882	33.3	0	.	p	.	0	Q376K	NONSYN	1126	1128	CAA	1382	1384	AAA	17;18;18	A;A;A	13;16;18	.	BaeS is a sensor kinase in the BaeSR regulatory system. While it phosphorylates BaeR to increase its activity, BaeS is not necessary for overexpressed BaeR to confer resistance.;baeS
baeS.3000829.AP009048.2165012_2166416.608	baeS.3000829.AP009048.2165012_2166416.608	1	0	539	1180	baeS	1404	1404	98.86	baeS.l15.c4.ctg.1	1882	33.3	0	.	p	.	0	G380E	NONSYN	1138	1140	GGG	1394	1396	GAG	15;17;16	G;A;G	14;15;16	.	BaeS is a sensor kinase in the BaeSR regulatory system. While it phosphorylates BaeR to increase its activity, BaeS is not necessary for overexpressed BaeR to confer resistance.;baeS
baeS.3000829.AP009048.2165012_2166416.608	baeS.3000829.AP009048.2165012_2166416.608	1	0	539	1180	baeS	1404	1404	98.86	baeS.l15.c4.ctg.1	1882	33.3	0	.	p	.	0	R382H	NONSYN	1144	1146	CGC	1400	1402	CAC	17;17;17	C;A;C	16;15;15	.	BaeS is a sensor kinase in the BaeSR regulatory system. While it phosphorylates BaeR to increase its activity, BaeS is not necessary for overexpressed BaeR to confer resistance.;baeS
baeS.3000829.AP009048.2165012_2166416.608	baeS.3000829.AP009048.2165012_2166416.608	1	0	539	1180	baeS	1404	1404	98.86	baeS.l15.c4.ctg.1	1882	33.3	0	.	p	.	0	D400E	NONSYN	1198	1200	GAT	1454	1456	GAG	22;22;22	G;A;G	22;22;22	.	BaeS is a sensor kinase in the BaeSR regulatory system. While it phosphorylates BaeR to increase its activity, BaeS is not necessary for overexpressed BaeR to confer resistance.;baeS
cpxA.3000830.NC_002695.4903561_4904935.605	cpxA.3000830.NC_002695.4903561_4904935.605	1	0	27	1340	cpxA	1374	1374	98.91	cpxA.l15.c30.ctg.1	1798	39.6	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	CpxA is a membrane-localized sensor kinase that is activated by envelope stress. It starts a kinase cascade that activates CpxR, which promotes efflux complex expression.;cpxA
cpxR.3000831.NC_002695.4904931_4905630.142	cpxR.3000831.NC_002695.4904931_4905630.142	1	0	27	850	cpxR	699	699	99.43	cpxR.l6.c30.ctg.1	1286	35.2	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	CpxR is a regulator that promotes acrD expression when phosphorylated by a cascade involving CpxA, a sensor kinase.;cpxR
cysB.3003840.NC_000913.3.1333854_1334829.3604	cysB.3003840.NC_000913.3.1333854_1334829.3604	1	0	539	942	cysB	975	975	99.28	cysB.l15.c4.ctg.1	1507	33.4	0	.	p	.	0	A146T	NONSYN	436	438	GCT	697	699	ACT	36;34;33	A;C;T	35;32;33	.	Positive regulator of gene expression in the cysteine regulon. cysB mutants confer resistance to novobiocin, an aminocoumarin antibiotic, in Escherichia coli.;aminocoumarin resistant cysB
dfrA1.manually_added_NC_007384_WP_000777554.1_4111923_4112396	dfrA1.manually_added_NC_007384_WP_000777554.1_4111923_4112396	1	0	27	604	dfrA1_1	474	474	100.0	dfrA1_1.l15.c4.ctg.1	1069	30.1	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Original ref seq: NC_007384.1 Shigella sonnei Ss046, complete genome
emrA.3000027.AP009048.2810082_2811255.411	emrA.3000027.AP009048.2810082_2811255.411	1	0	539	1108	emrA	1173	1173	98.29	emrA.l15.c30.ctg.1	1712	34.6	0	.	p	.	0	I219V	NONSYN	655	657	ATC	934	936	GTC	47;47;48	G;T;C	45;45;48	.	emrA;EmrA is a membrane fusion protein, providing an efflux pathway with EmrB and TolC between the inner and outer membranes of E. coli, a Gram-negative bacterium.
emrB.3000074.U00096.2812615_2814154.20	emrB.3000074.U00096.2812615_2814154.20	1	0	539	1638	emrB	1539	1539	99.74	emrB.l15.c4.ctg.1	2151	40.6	0	.	p	.	0	E197K	NONSYN	589	591	GAA	929	931	AAA	56;57;59	A;A;A	56;57;59	.	emrB is a translocase in the emrB -TolC efflux protein in E. coli. It recognizes substrates including carbonyl cyanide m-chlorophenylhydrazone (CCCP), nalidixic acid, and thioloactomycin.;emrB
emrD.3000309.GG749185.1.116812_118003.3622	emrD.3000309.GG749185.1.116812_118003.3622	1	0	539	1032	emrD	1191	1191	98.4	emrD.l6.c30.ctg.1	1710	32.3	0	.	p	.	0	G209S	NONSYN	625	627	GGC	896	898	AGC	31;31;30	A;G;C	31;31;30	.	EmrD is a multidrug transporter from the Major Facilitator Superfamily (MFS) primarily found in Escherichia coli. EmrD couples efflux of amphipathic compounds with proton import across the plasma membrane.;emrD
emrE.3000264.NC_007779.567537_567870.260	emrE.3000264.NC_007779.567537_567870.260	1	0	16	50	emrE_1	333	95	96.84	emrE_1.l15.c30.ctg.1	175	7.1	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	EmrE is a small multidrug transporter that functions as a homodimer and that couples the efflux of small polyaromatic cations from the cell with the import of protons down an electrochemical gradient. EmrE is found in E. coli and P. aeruginosa.;emrE
emrK.3000206.D78168.536_1592.173	emrK.3000206.D78168.536_1592.173	1	0	539	916	emrK	1056	1056	98.2	emrK.l15.c30.ctg.1	1699	28.8	0	.	p	.	0	K176R	NONSYN	526	528	AAG	827	829	AGG	24;24;24	A;G;G	24;24;24	.	emrK is a membrane fusion protein that is a homolog of EmrA. Together with the inner membrane transporter EmrY and the outer membrane channel TolC, it mediates multidrug efflux.;emrK
emrK.3000206.D78168.536_1592.173	emrK.3000206.D78168.536_1592.173	1	0	539	916	emrK	1056	1056	98.2	emrK.l15.c30.ctg.1	1699	28.8	0	.	p	.	0	N306D	NONSYN	916	918	AAC	1217	1219	GAC	22;20;20	G;A;C	22;20;20	.	emrK is a membrane fusion protein that is a homolog of EmrA. Together with the inner membrane transporter EmrY and the outer membrane channel TolC, it mediates multidrug efflux.;emrK
emrR.3000516.NC_000913.3.2810769_2811300.3621	emrR.3000516.NC_000913.3.2810769_2811300.3621	1	0	27	650	emrR	531	531	100.0	emrR.l15.c4.ctg.1	1089	32.0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	emrR;EmrR is a negative regulator for the EmrAB-TolC multidrug efflux pump in E. coli. Mutations lead to EmrAB-TolC overexpression.
emrY.3000254.D78168.1591_3130.65	emrY.3000254.D78168.1591_3130.65	1	0	27	1472	emrY	1539	1539	99.81	emrY.l15.c4.ctg.1	2079	37.5	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	emrY;emrY is a multidrug transport that moves substrates across the inner membrane of the Gram-negative E. coli. It is a homolog of emrB.
evgA.3000832.NC_002695.3211891_3212506.208	evgA.3000832.NC_002695.3211891_3212506.208	1	0	539	612	evgA	615	615	99.19	evgA.l6.c30.ctg.1	1260	25.8	0	.	p	.	0	Q62L	NONSYN	184	186	CAG	495	497	CTG	28;27;27	C;T;G	28;27;27	.	EvgA, when phosphorylated, is a positive regulator for efflux protein complexes emrKY and mdtEF. While usually phosphorylated in a EvgS dependent manner, it can be phosphorylated in the absence of EvgS when overexpressed.;evgA
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	2770	evgS	3594	3594	97.52	evgS.l15.c4.ctg.1	4124	35.9	0	.	p	.	0	T38I	NONSYN	112	114	ACA	345	347	ATA	14;13;13	A;T;A	14;13;13	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	2770	evgS	3594	3594	97.52	evgS.l15.c4.ctg.1	4124	35.9	0	.	p	.	0	L42V	NONSYN	124	126	CTA	357	359	GTA	13;13;14	G;T;A	13;13;14	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	2770	evgS	3594	3594	97.52	evgS.l15.c4.ctg.1	4124	35.9	0	.	p	.	0	A93T	NONSYN	277	279	GCG	510	512	ACG	22;24;24	A;C;G	22;24;24	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	2770	evgS	3594	3594	97.52	evgS.l15.c4.ctg.1	4124	35.9	0	.	p	.	0	A114E	NONSYN	340	342	GCA	573	575	GAA	39;39;39	G;A;A	38;39;39	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	2770	evgS	3594	3594	97.52	evgS.l15.c4.ctg.1	4124	35.9	0	.	p	.	0	T127A	NONSYN	379	381	ACT	612	614	GCT	44;45;44	G;C;T	44;45;44	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	2770	evgS	3594	3594	97.52	evgS.l15.c4.ctg.1	4124	35.9	0	.	p	.	0	N133D	NONSYN	397	399	AAT	630	632	GAT	37;37;37	G;A;T	37;37;37	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	2770	evgS	3594	3594	97.52	evgS.l15.c4.ctg.1	4124	35.9	0	.	p	.	0	P162S	NONSYN	484	486	CCA	717	719	TCA	23;22;22	T;C;A	22;21;22	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	2770	evgS	3594	3594	97.52	evgS.l15.c4.ctg.1	4124	35.9	0	.	p	.	0	H205Q	NONSYN	613	615	CAC	846	848	CAG	19;19;17	C;A;G	19;19;17	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	2770	evgS	3594	3594	97.52	evgS.l15.c4.ctg.1	4124	35.9	0	.	p	.	0	I251V	NONSYN	751	753	ATT	984	986	GTT	32;31;31	G;T;T	32;31;31	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	2770	evgS	3594	3594	97.52	evgS.l15.c4.ctg.1	4124	35.9	0	.	p	.	0	N303D	NONSYN	907	909	AAT	1140	1142	GAT	22;22;22	G,A;A;T	21,1;22;22	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	2770	evgS	3594	3594	97.52	evgS.l15.c4.ctg.1	4124	35.9	0	.	p	.	0	S359N	NONSYN	1075	1077	AGC	1308	1310	AAT	20;20;18	A;A;T	20;20;18	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	2770	evgS	3594	3594	97.52	evgS.l15.c4.ctg.1	4124	35.9	0	.	p	.	0	I366L	NONSYN	1096	1098	ATA	1329	1331	TTA	7;7;6	T;T;A	7;7;6	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	2770	evgS	3594	3594	97.52	evgS.l15.c4.ctg.1	4124	35.9	0	.	p	.	0	Q433K	NONSYN	1297	1299	CAG	1530	1532	AAA	23;22;23	A;A;A	23;22;23	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	2770	evgS	3594	3594	97.52	evgS.l15.c4.ctg.1	4124	35.9	0	.	p	.	0	N678H	NONSYN	2032	2034	AAT	2265	2267	CAT	24;23;23	C;A;T	23;22;23	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	2770	evgS	3594	3594	97.52	evgS.l15.c4.ctg.1	4124	35.9	0	.	p	.	0	N696H	NONSYN	2086	2088	AAT	2319	2321	CAT	27;26;26	C;A;T	27;26;26	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	2770	evgS	3594	3594	97.52	evgS.l15.c4.ctg.1	4124	35.9	0	.	p	.	0	K702R	NONSYN	2104	2106	AAA	2337	2339	AGA	31;31;30	A;G;A	31;31;30	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	2770	evgS	3594	3594	97.52	evgS.l15.c4.ctg.1	4124	35.9	0	.	p	.	0	K707N	NONSYN	2119	2121	AAG	2352	2354	AAT	29;29;28	A;A;T	29;29;28	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	2770	evgS	3594	3594	97.52	evgS.l15.c4.ctg.1	4124	35.9	0	.	p	.	0	A756S	NONSYN	2266	2268	GCC	2499	2501	TCC	23;23;23	T;C;C	23;23;23	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	2770	evgS	3594	3594	97.52	evgS.l15.c4.ctg.1	4124	35.9	0	.	p	.	0	S811I	NONSYN	2431	2433	AGT	2664	2666	ATT	17;16;18	A;T;T	16;16;18	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	2770	evgS	3594	3594	97.52	evgS.l15.c4.ctg.1	4124	35.9	0	.	p	.	0	E818D	NONSYN	2452	2454	GAA	2685	2687	GAT	14;17;17	G;A;T	14;17;17	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	2770	evgS	3594	3594	97.52	evgS.l15.c4.ctg.1	4124	35.9	0	.	p	.	0	G856V	NONSYN	2566	2568	GGT	2799	2801	GTT	49;49;53	G;T;T	48;48;53	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	2770	evgS	3594	3594	97.52	evgS.l15.c4.ctg.1	4124	35.9	0	.	p	.	0	Q951H	NONSYN	2851	2853	CAA	3084	3086	CAC	39;39;43	C;A;C	39;39;43	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
folP.3003386.NC_007779.3323917_3324766.2056	folP.3003386.NC_007779.3323917_3324766.2056	1	1	27	884	folP_1	849	849	99.29	folP_1.l15.c4.ctg.1	1303	36.2	1	SNP	p	P64A	0	.	.	190	192	CCA	440	442	CCA	74;75;77	C;C;A	74;74;71	folP.3003386.NC_007779.3323917_3324766.2056:1:1:P64A:.:Point mutations in Escherichia coli dihydropteroate synthase folP prevent sulfonamide antibiotics from inhibiting its role in folate synthesis, thus conferring sulfonamide resistance.	Escherichia coli sulfonamide resistant mutant folP
folP.3003386.NC_007779.3323917_3324766.2056	folP.3003386.NC_007779.3323917_3324766.2056	1	1	27	884	folP_1	849	849	99.29	folP_1.l15.c4.ctg.1	1303	36.2	1	SNP	p	P64L	0	.	.	190	192	CCA	440	442	CCA	74;75;77	C;C;A	74;74;71	folP.3003386.NC_007779.3323917_3324766.2056:1:1:P64L:.:Point mutations in Escherichia coli dihydropteroate synthase folP prevent sulfonamide antibiotics from inhibiting its role in folate synthesis, thus conferring sulfonamide resistance.	Escherichia coli sulfonamide resistant mutant folP
folP.3003386.NC_007779.3323917_3324766.2056	folP.3003386.NC_007779.3323917_3324766.2056	1	1	27	884	folP_1	849	849	99.29	folP_1.l15.c4.ctg.1	1303	36.2	1	SNP	p	P64R	0	.	.	190	192	CCA	440	442	CCA	74;75;77	C;C;A	74;74;71	folP.3003386.NC_007779.3323917_3324766.2056:1:1:P64R:.:Point mutations in Escherichia coli dihydropteroate synthase folP prevent sulfonamide antibiotics from inhibiting its role in folate synthesis, thus conferring sulfonamide resistance.	Escherichia coli sulfonamide resistant mutant folP
folP.3003386.NC_007779.3323917_3324766.2056	folP.3003386.NC_007779.3323917_3324766.2056	1	1	27	884	folP_1	849	849	99.29	folP_1.l15.c4.ctg.1	1303	36.2	1	SNP	p	P64H	0	.	.	190	192	CCA	440	442	CCA	74;75;77	C;C;A	74;74;71	folP.3003386.NC_007779.3323917_3324766.2056:1:1:P64H:.:Point mutations in Escherichia coli dihydropteroate synthase folP prevent sulfonamide antibiotics from inhibiting its role in folate synthesis, thus conferring sulfonamide resistance.	Escherichia coli sulfonamide resistant mutant folP
folP.3003386.NC_007779.3323917_3324766.2056	folP.3003386.NC_007779.3323917_3324766.2056	1	1	27	884	folP_1	849	849	99.29	folP_1.l15.c4.ctg.1	1303	36.2	1	SNP	p	P64S	0	.	.	190	192	CCA	440	442	CCA	74;75;77	C;C;A	74;74;71	folP.3003386.NC_007779.3323917_3324766.2056:1:1:P64S:.:Point mutations in Escherichia coli dihydropteroate synthase folP prevent sulfonamide antibiotics from inhibiting its role in folate synthesis, thus conferring sulfonamide resistance.	Escherichia coli sulfonamide resistant mutant folP
gadE.3003834.NC_000913.3.3658365_3658893.3597	gadE.3003834.NC_000913.3.3658365_3658893.3597	1	0	27	610	gadE	528	528	100.0	gadE.l15.c4.ctg.1	1156	28.2	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	gadE;gadE is a DNA-binding transcriptional activator that regulates the expression of genes involved in acid resistance. It is required for the expression of gadA and gadBC.
gadW.3003838.CP015085.1.2551711_2552440.3599	gadW.3003838.CP015085.1.2551711_2552440.3599	1	0	512	140	gadW	729	251	96.02	gadW.l15.c4.ctg.1	432	11.2	0	.	p	.	0	S234A	NONSYN	700	702	TCG	222	224	GCG	7;7;7	G;C;G	7;7;7	.	GadW is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance. GadW inhibits GadX-dependent activation. GadW clearly represses gadX and, in situations where GadX is missing, activates gadA and gadBC.;gadW
gadW.3003838.CP015085.1.2551711_2552440.3599	gadW.3003838.CP015085.1.2551711_2552440.3599	1	0	512	140	gadW	729	381	93.44	gadW.l15.c4.ctg.2	381	6.8	0	.	p	.	0	L31V	NONSYN	91	93	CTG	15	17	GTG	2;2;2	G;T;G	2;2;2	.	GadW is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance. GadW inhibits GadX-dependent activation. GadW clearly represses gadX and, in situations where GadX is missing, activates gadA and gadBC.;gadW
gadW.3003838.CP015085.1.2551711_2552440.3599	gadW.3003838.CP015085.1.2551711_2552440.3599	1	0	512	140	gadW	729	381	93.44	gadW.l15.c4.ctg.2	381	6.8	0	.	p	.	0	D34E	NONSYN	100	102	GAT	24	26	GAG	2;2;2	G;A;G	2;2;2	.	GadW is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance. GadW inhibits GadX-dependent activation. GadW clearly represses gadX and, in situations where GadX is missing, activates gadA and gadBC.;gadW
gadW.3003838.CP015085.1.2551711_2552440.3599	gadW.3003838.CP015085.1.2551711_2552440.3599	1	0	512	140	gadW	729	381	93.44	gadW.l15.c4.ctg.2	381	6.8	0	.	p	.	0	L46P	NONSYN	136	138	CTG	60	62	CCG	3;3;4	C;C;G	3;3;4	.	GadW is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance. GadW inhibits GadX-dependent activation. GadW clearly represses gadX and, in situations where GadX is missing, activates gadA and gadBC.;gadW
gadW.3003838.CP015085.1.2551711_2552440.3599	gadW.3003838.CP015085.1.2551711_2552440.3599	1	0	512	140	gadW	729	381	93.44	gadW.l15.c4.ctg.2	381	6.8	0	.	p	.	0	E54D	NONSYN	160	162	GAA	84	86	GAT	3;4;4	G;A;T	3;4;4	.	GadW is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance. GadW inhibits GadX-dependent activation. GadW clearly represses gadX and, in situations where GadX is missing, activates gadA and gadBC.;gadW
gadW.3003838.CP015085.1.2551711_2552440.3599	gadW.3003838.CP015085.1.2551711_2552440.3599	1	0	512	140	gadW	729	381	93.44	gadW.l15.c4.ctg.2	381	6.8	0	.	p	.	0	I88M	NONSYN	262	264	ATA	186	188	ATG	4;4;3	A;T;G	4;4;3	.	GadW is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance. GadW inhibits GadX-dependent activation. GadW clearly represses gadX and, in situations where GadX is missing, activates gadA and gadBC.;gadW
gadW.3003838.CP015085.1.2551711_2552440.3599	gadW.3003838.CP015085.1.2551711_2552440.3599	1	0	512	140	gadW	729	381	93.44	gadW.l15.c4.ctg.2	381	6.8	0	.	p	.	0	Q89P	NONSYN	265	267	CAG	189	191	CCG	3;4;4	C;C;G	3;4;4	.	GadW is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance. GadW inhibits GadX-dependent activation. GadW clearly represses gadX and, in situations where GadX is missing, activates gadA and gadBC.;gadW
gadW.3003838.CP015085.1.2551711_2552440.3599	gadW.3003838.CP015085.1.2551711_2552440.3599	1	0	512	140	gadW	729	381	93.44	gadW.l15.c4.ctg.2	381	6.8	0	.	p	.	0	D100E	NONSYN	298	300	GAC	222	224	GAA	3;3;3	G;A;A	3;3;3	.	GadW is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance. GadW inhibits GadX-dependent activation. GadW clearly represses gadX and, in situations where GadX is missing, activates gadA and gadBC.;gadW
gadW.3003838.CP015085.1.2551711_2552440.3599	gadW.3003838.CP015085.1.2551711_2552440.3599	1	0	512	140	gadW	729	381	93.44	gadW.l15.c4.ctg.2	381	6.8	0	.	p	.	0	P101S	NONSYN	301	303	CCC	225	227	TCC	3;3;3	T;C;C	3;3;3	.	GadW is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance. GadW inhibits GadX-dependent activation. GadW clearly represses gadX and, in situations where GadX is missing, activates gadA and gadBC.;gadW
gadW.3003838.CP015085.1.2551711_2552440.3599	gadW.3003838.CP015085.1.2551711_2552440.3599	1	0	512	140	gadW	729	381	93.44	gadW.l15.c4.ctg.2	381	6.8	0	.	p	.	0	R102G	NONSYN	304	306	CGG	228	230	GGG	3;3;3	G;G;G	3;3;3	.	GadW is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance. GadW inhibits GadX-dependent activation. GadW clearly represses gadX and, in situations where GadX is missing, activates gadA and gadBC.;gadW
gadW.3003838.CP015085.1.2551711_2552440.3599	gadW.3003838.CP015085.1.2551711_2552440.3599	1	0	512	140	gadW	729	381	93.44	gadW.l15.c4.ctg.2	381	6.8	0	.	p	.	0	K110N	NONSYN	328	330	AAA	252	254	AAT	6;6;6	A;A;T	6;6;6	.	GadW is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance. GadW inhibits GadX-dependent activation. GadW clearly represses gadX and, in situations where GadX is missing, activates gadA and gadBC.;gadW
gadX.3000508.NC_007779.3974604_3975429.615	gadX.3000508.NC_007779.3974604_3975429.615	1	0	539	574	gadX	825	825	97.94	gadX.l15.c17.ctg.1	1262	23.9	0	.	p	.	0	F53L	NONSYN	157	159	TTC	324	326	TTA	30;29;28	T;T;A	30;29;28	.	gadX;GadX is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance.
gadX.3000508.NC_007779.3974604_3975429.615	gadX.3000508.NC_007779.3974604_3975429.615	1	0	539	574	gadX	825	825	97.94	gadX.l15.c17.ctg.1	1262	23.9	0	.	p	.	0	V79I	NONSYN	235	237	GTT	402	404	ATT	17;17;17	A;T;T	17;17;17	.	gadX;GadX is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance.
gadX.3000508.NC_007779.3974604_3975429.615	gadX.3000508.NC_007779.3974604_3975429.615	1	0	539	574	gadX	825	825	97.94	gadX.l15.c17.ctg.1	1262	23.9	0	.	p	.	0	R246G	NONSYN	736	738	AGA	903	905	GGA	29;28;28	G;G;A	29;28;28	.	gadX;GadX is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance.
gadX.3000508.NC_007779.3974604_3975429.615	gadX.3000508.NC_007779.3974604_3975429.615	1	0	539	574	gadX	825	825	97.94	gadX.l15.c17.ctg.1	1262	23.9	0	.	p	.	0	S248P	NONSYN	742	744	TCG	909	911	CCG	27;26;26	C;C;G	27;26;26	.	gadX;GadX is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance.
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	2836	gyrA_7	2628	2628	98.67	gyrA_7.l15.c30.ctg.1	3281	46.1	1	SNP	p	D87G	1	D87G	NONSYN	259	261	GAC	593	595	GGC	45;46;43	G;G;C	44;45;40	gyrA.3003294.U00096.2336792_2339420.2052:1:1:D87G:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	2836	gyrA_7	2628	2628	98.67	gyrA_7.l15.c30.ctg.1	3281	46.1	0	.	p	.	0	D678E	NONSYN	2032	2034	GAC	2366	2368	GAA	51;51;51	G;A;A	50;51;50	.	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	2836	gyrA_7	2628	2628	98.67	gyrA_7.l15.c30.ctg.1	3281	46.1	1	SNP	p	S83L	0	.	.	247	249	TCG	581	583	TCG	50;48;47	T;C;G	49;46;46	gyrA.3003294.U00096.2336792_2339420.2052:1:1:S83L:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	2836	gyrA_7	2628	2628	98.67	gyrA_7.l15.c30.ctg.1	3281	46.1	1	SNP	p	S83W	0	.	.	247	249	TCG	581	583	TCG	50;48;47	T;C;G	49;46;46	gyrA.3003294.U00096.2336792_2339420.2052:1:1:S83W:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	2836	gyrA_7	2628	2628	98.67	gyrA_7.l15.c30.ctg.1	3281	46.1	1	SNP	p	S83I	0	.	.	247	249	TCG	581	583	TCG	50;48;47	T;C;G	49;46;46	gyrA.3003294.U00096.2336792_2339420.2052:1:1:S83I:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	27	2404	gyrB_1	2415	2415	99.05	gyrB_1.l15.c4.ctg.1	2978	43.2	1	SNP	p	R136G	0	.	.	406	408	CGC	677	679	CGC	50;50;48	C;G;C	48;48;48	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136G:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	27	2404	gyrB_1	2415	2415	99.05	gyrB_1.l15.c4.ctg.1	2978	43.2	1	SNP	p	R136C	0	.	.	406	408	CGC	677	679	CGC	50;50;48	C;G;C	48;48;48	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136C:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	27	2404	gyrB_1	2415	2415	99.05	gyrB_1.l15.c4.ctg.1	2978	43.2	1	SNP	p	R136E	0	.	.	406	408	CGC	677	679	CGC	50;50;48	C;G;C	48;48;48	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136E:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	27	2404	gyrB_1	2415	2415	99.05	gyrB_1.l15.c4.ctg.1	2978	43.2	1	SNP	p	R136L	0	.	.	406	408	CGC	677	679	CGC	50;50;48	C;G;C	48;48;48	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136L:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	27	2404	gyrB_1	2415	2415	99.05	gyrB_1.l15.c4.ctg.1	2978	43.2	1	SNP	p	R136S	0	.	.	406	408	CGC	677	679	CGC	50;50;48	C;G;C	48;48;48	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136S:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	27	2404	gyrB_1	2415	2415	99.05	gyrB_1.l15.c4.ctg.1	2978	43.2	1	SNP	p	R136H	0	.	.	406	408	CGC	677	679	CGC	50;50;48	C;G;C	48;48;48	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136H:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	27	2404	gyrB_1	2415	2415	99.05	gyrB_1.l15.c4.ctg.1	2978	43.2	1	SNP	p	R136I	0	.	.	406	408	CGC	677	679	CGC	50;50;48	C;G;C	48;48;48	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136I:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
kdpE.3003841.NC_000913.3.721055_721733.3608	kdpE.3003841.NC_000913.3.721055_721733.3608	1	0	539	546	kdpE	678	678	98.23	kdpE.l15.c4.ctg.1	1189	24.6	0	.	p	.	0	A72P	NONSYN	214	216	GCG	483	485	CCG	40;39;37	C;C;G	40;38;37	.	kdpE;kdpE is a transcriptional activator that is part of the two-component system KdpD/KdpE that is studied for its regulatory role in potassium transport and has been identified as an adaptive regulator involved in the virulence and intracellular survival of pathogenic bacteria. kdpE regulates a range of virulence loci through direct promoter binding.
kdpE.3003841.NC_000913.3.721055_721733.3608	kdpE.3003841.NC_000913.3.721055_721733.3608	1	0	539	546	kdpE	678	678	98.23	kdpE.l15.c4.ctg.1	1189	24.6	0	.	p	.	0	T123A	NONSYN	367	369	ACC	636	638	GCC	21;21;22	G;C;C	21;21;22	.	kdpE;kdpE is a transcriptional activator that is part of the two-component system KdpD/KdpE that is studied for its regulatory role in potassium transport and has been identified as an adaptive regulator involved in the virulence and intracellular survival of pathogenic bacteria. kdpE regulates a range of virulence loci through direct promoter binding.
leuO.3003843.NC_000913.3.84367_85312.3607	leuO.3003843.NC_000913.3.84367_85312.3607	1	0	539	986	leuO	945	945	99.26	leuO.l15.c30.ctg.1	1474	35.7	0	.	p	.	0	P9S	NONSYN	25	27	CCA	263	265	TCA	34;34;36	T;C;A	34;34;36	.	leuO;leuO, a LysR family transcription factor, exists in a wide variety of bacteria of the family Enterobacteriaceae and is involved in the regulation of as yet unidentified genes affecting the stress response and pathogenesis expression.
marA.3000263.NC_007779.1621287_1621671.579	marA.3000263.NC_007779.1621287_1621671.579	1	0	27	420	marA	384	384	99.74	marA.l6.c4.ctg.1	877	25.4	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	marA;In the presence of antibiotic stress, E. coli overexpresses the global activator protein MarA, which besides inducing MDR efflux pump AcrAB, also down- regulates synthesis of the porin OmpF.
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	210	marR	435	435	97.47	marR.l6.c30.ctg.1	876	12.8	1	SNP	p	G103S	1	G103S	NONSYN	307	309	GGC	577	579	AGC	15;16;16	A;G;C	15;16;16	marR.3003378.U00096.1619119_1619554.2097:1:1:G103S:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	210	marR	435	435	97.47	marR.l6.c30.ctg.1	876	12.8	1	SNP	p	Y137H	1	Y137H	NONSYN	409	411	TAT	679	681	CAT	8;8;8	C;A;T	7;7;8	marR.3003378.U00096.1619119_1619554.2097:1:1:Y137H:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	210	marR	435	435	97.47	marR.l6.c30.ctg.1	876	12.8	0	.	p	.	0	V142A	NONSYN	424	426	GTC	694	696	GCC	3;2;2	G;C,T;C	2;0,1;2	.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	210	marR	435	435	97.47	marR.l6.c30.ctg.1	876	12.8	1	SNP	p	V45E	0	.	.	133	135	GTG	403	405	GTG	34;34;32	G;T;G	32;34;32	marR.3003378.U00096.1619119_1619554.2097:1:1:V45E:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	210	marR	435	435	97.47	marR.l6.c30.ctg.1	876	12.8	1	SNP	p	I49S	0	.	.	145	147	ATC	415	417	ATC	31;31;31	A;T;C	31;31;31	marR.3003378.U00096.1619119_1619554.2097:1:1:I49S:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	210	marR	435	435	97.47	marR.l6.c30.ctg.1	876	12.8	1	SNP	p	A70T	0	.	.	208	210	GCA	478	480	GCA	13;14;14	G;C;A	13;14;14	marR.3003378.U00096.1619119_1619554.2097:1:1:A70T:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	210	marR	435	435	97.47	marR.l6.c30.ctg.1	876	12.8	1	SNP	p	R73C	0	.	.	217	219	CGT	487	489	CGT	17;16;17	C;G;T	17;16;17	marR.3003378.U00096.1619119_1619554.2097:1:1:R73C:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	210	marR	435	435	97.47	marR.l6.c30.ctg.1	876	12.8	1	SNP	p	R73S	0	.	.	217	219	CGT	487	489	CGT	17;16;17	C;G;T	17;16;17	marR.3003378.U00096.1619119_1619554.2097:1:1:R73S:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	210	marR	435	435	97.47	marR.l6.c30.ctg.1	876	12.8	1	SNP	p	R77C	0	.	.	229	231	CGC	499	501	CGC	16;16;16	C;G;C	16;16;16	marR.3003378.U00096.1619119_1619554.2097:1:1:R77C:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	210	marR	435	435	97.47	marR.l6.c30.ctg.1	876	12.8	1	SNP	p	R77L	0	.	.	229	231	CGC	499	501	CGC	16;16;16	C;G;C	16;16;16	marR.3003378.U00096.1619119_1619554.2097:1:1:R77L:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	210	marR	435	435	97.47	marR.l6.c30.ctg.1	876	12.8	1	SNP	p	L78M	0	.	.	232	234	CTG	502	504	CTG	17;15;14	C;T;G	17;15;14	marR.3003378.U00096.1619119_1619554.2097:1:1:L78M:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	210	marR	435	435	97.47	marR.l6.c30.ctg.1	876	12.8	1	SNP	p	R94S	0	.	.	280	282	CGC	550	552	CGC	13;13;13	C;G;C	13;13;13	marR.3003378.U00096.1619119_1619554.2097:1:1:R94S:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	210	marR	435	435	97.47	marR.l6.c30.ctg.1	876	12.8	1	SNP	p	R94H	0	.	.	280	282	CGC	550	552	CGC	13;13;13	C;G;C	13;13;13	marR.3003378.U00096.1619119_1619554.2097:1:1:R94H:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	210	marR	435	435	97.47	marR.l6.c30.ctg.1	876	12.8	1	SNP	p	V96E	0	.	.	286	288	GTA	556	558	GTA	12;12;12	G;T;A	12;12;12	marR.3003378.U00096.1619119_1619554.2097:1:1:V96E:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	768	mdfA	1233	1233	97.0	mdfA.l15.c17.ctg.1	1430	27.9	0	.	p	.	0	S7F	NONSYN	19	21	TCC	30	32	TTC	10;10;10	T;T;C	10;10;10	.	mdfA;Multidrug translocase MdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	768	mdfA	1233	1233	97.0	mdfA.l15.c17.ctg.1	1430	27.9	0	.	p	.	0	R36I	NONSYN	106	108	AGG	117	119	ATC	14;14;13	A;T;C	14;14;13	.	mdfA;Multidrug translocase MdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	768	mdfA	1233	1233	97.0	mdfA.l15.c17.ctg.1	1430	27.9	0	.	p	.	0	E42A	NONSYN	124	126	GAA	135	137	GCC	12;12;12	G;C;C	12;12;12	.	mdfA;Multidrug translocase MdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	768	mdfA	1233	1233	97.0	mdfA.l15.c17.ctg.1	1430	27.9	0	.	p	.	0	N43V	NONSYN	127	129	AAT	138	140	GTG	12;12;13	G;T;G	12;12;13	.	mdfA;Multidrug translocase MdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	768	mdfA	1233	1233	97.0	mdfA.l15.c17.ctg.1	1430	27.9	0	.	p	.	0	E52D	NONSYN	154	156	GAG	165	167	GAT	16;16;16	G;A;T	16;16;16	.	mdfA;Multidrug translocase MdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	768	mdfA	1233	1233	97.0	mdfA.l15.c17.ctg.1	1430	27.9	0	.	p	.	0	N59T	NONSYN	175	177	AAC	186	188	ACC	9;10;11	A;C;C	9;10;11	.	mdfA;Multidrug translocase MdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	768	mdfA	1233	1233	97.0	mdfA.l15.c17.ctg.1	1430	27.9	0	.	p	.	0	I68L	NONSYN	202	204	ATA	213	215	TTA	15;13;13	T;T;A	15;13;13	.	mdfA;Multidrug translocase MdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	768	mdfA	1233	1233	97.0	mdfA.l15.c17.ctg.1	1430	27.9	0	.	p	.	0	H115Q	NONSYN	343	345	CAC	354	356	CAG	44;45;44	C;A;G	44;45;44	.	mdfA;Multidrug translocase MdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	768	mdfA	1233	1233	97.0	mdfA.l15.c17.ctg.1	1430	27.9	0	.	p	.	0	D128A	NONSYN	382	384	GAC	393	395	GCC	29;29;29	G;C;C	29;29;29	.	mdfA;Multidrug translocase MdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	768	mdfA	1233	1233	97.0	mdfA.l15.c17.ctg.1	1430	27.9	0	.	p	.	0	S163A	NONSYN	487	489	TCG	498	500	GCG	27;26;28	G;C;G	27;26;28	.	mdfA;Multidrug translocase MdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	768	mdfA	1233	1233	97.0	mdfA.l15.c17.ctg.1	1430	27.9	0	.	p	.	0	L231V	NONSYN	691	693	CTT	702	704	GTT	16;15;16	G;T;T	10;14;14	.	mdfA;Multidrug translocase MdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	768	mdfA	1233	1233	97.0	mdfA.l15.c17.ctg.1	1430	27.9	0	.	p	.	0	R285fs	FSHIFT	853	853	C	864	864	C	29	C	29	.	mdfA;Multidrug translocase MdfA
mdtA.3000792.U00096.2154015_2155263.15	mdtA.3000792.U00096.2154015_2155263.15	1	0	539	840	mdtA	1248	1248	97.36	mdtA.l15.c30.ctg.1	1636	27.2	0	.	p	.	0	V12trunc	TRUNC	34	34	G	226	226	G	29	G	29	.	MdtA is the membrane fusion protein of the multidrug efflux complex mdtABC.;mdtA
mdtA.3000792.U00096.2154015_2155263.15	mdtA.3000792.U00096.2154015_2155263.15	1	0	539	840	mdtA	1248	1248	97.36	mdtA.l15.c30.ctg.1	1636	27.2	0	.	p	.	0	R33Q	NONSYN	97	99	CGG	283	285	CAG	16;20;22	C;A;G	16;20;22	.	MdtA is the membrane fusion protein of the multidrug efflux complex mdtABC.;mdtA
mdtA.3000792.U00096.2154015_2155263.15	mdtA.3000792.U00096.2154015_2155263.15	1	0	539	840	mdtA	1248	1248	97.36	mdtA.l15.c30.ctg.1	1636	27.2	0	.	p	.	0	T83I	NONSYN	247	249	ACC	433	435	ATC	18;18;18	A;T;C	17;16;17	.	MdtA is the membrane fusion protein of the multidrug efflux complex mdtABC.;mdtA
mdtA.3000792.U00096.2154015_2155263.15	mdtA.3000792.U00096.2154015_2155263.15	1	0	539	840	mdtA	1248	1248	97.36	mdtA.l15.c30.ctg.1	1636	27.2	0	.	p	.	0	I99M	NONSYN	295	297	ATA	481	483	ATG	23;22;22	A;T;G	23;22;22	.	MdtA is the membrane fusion protein of the multidrug efflux complex mdtABC.;mdtA
mdtA.3000792.U00096.2154015_2155263.15	mdtA.3000792.U00096.2154015_2155263.15	1	0	539	840	mdtA	1248	1248	97.36	mdtA.l15.c30.ctg.1	1636	27.2	0	.	p	.	0	A130T	NONSYN	388	390	GCC	574	576	ACC	27;27;27	A;C;C	27;27;27	.	MdtA is the membrane fusion protein of the multidrug efflux complex mdtABC.;mdtA
mdtA.3000792.U00096.2154015_2155263.15	mdtA.3000792.U00096.2154015_2155263.15	1	0	539	840	mdtA	1248	1248	97.36	mdtA.l15.c30.ctg.1	1636	27.2	0	.	p	.	0	P257T	NONSYN	769	771	CCG	955	957	ACG	29;31;33	A;C;G	29;31;33	.	MdtA is the membrane fusion protein of the multidrug efflux complex mdtABC.;mdtA
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	2860	mdtB	3123	3123	98.98	mdtB.l6.c17.ctg.1	3571	42.9	0	.	p	.	0	A583T	NONSYN	1747	1749	GCC	2022	2024	ACC	52;53;54	A;C;C	52;53;54	.	mdtB;MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	2860	mdtB	3123	3123	98.98	mdtB.l6.c17.ctg.1	3571	42.9	0	.	p	.	0	K714Q	NONSYN	2140	2142	AAA	2415	2417	CAA	25;26;25	C;A;A	24;26;25	.	mdtB;MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	2860	mdtB	3123	3123	98.98	mdtB.l6.c17.ctg.1	3571	42.9	0	.	p	.	0	N770I	NONSYN	2308	2310	AAT	2583	2585	ATT	28;27;28	A;T;T	28;27;27	.	mdtB;MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	2860	mdtB	3123	3123	98.98	mdtB.l6.c17.ctg.1	3571	42.9	0	.	p	.	0	I798V	NONSYN	2392	2394	ATT	2667	2669	GTT	30;30;30	G;T;T	30;30;30	.	mdtB;MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	2860	mdtB	3123	3123	98.98	mdtB.l6.c17.ctg.1	3571	42.9	0	.	p	.	0	A834E	NONSYN	2500	2502	GCG	2775	2777	GAG	29;29;31	G;A;G	29;28;31	.	mdtB;MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	2860	mdtB	3123	3123	98.98	mdtB.l6.c17.ctg.1	3571	42.9	0	.	p	.	0	L910M	NONSYN	2728	2730	CTG	3003	3005	ATG	28;28;30	A;T;G	28;28;30	.	mdtB;MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	2860	mdtB	3123	3123	98.98	mdtB.l6.c17.ctg.1	3571	42.9	0	.	p	.	0	E955D	NONSYN	2863	2865	GAG	3138	3140	GAT	32;34;35	G;A;T	32;34;35	.	mdtB;MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.
mdtC.3000794.U00096.2158385_2161463.257	mdtC.3000794.U00096.2158385_2161463.257	1	0	539	2480	mdtC	3078	3078	98.64	mdtC.l15.c17.ctg.1	3462	38.1	0	.	p	.	0	I46M	NONSYN	136	138	ATC	325	327	ATG	16;16;14	A;T;G	15;15;14	.	MdtC is a transporter that forms a heteromultimer complex with MdtB to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex. In the absence of MdtB, MdtC can form a homomultimer complex that results in a functioning efflux complex with a narrower drug specificity.;mdtC
mdtC.3000794.U00096.2158385_2161463.257	mdtC.3000794.U00096.2158385_2161463.257	1	0	539	2480	mdtC	3078	3078	98.64	mdtC.l15.c17.ctg.1	3462	38.1	0	.	p	.	0	V208I	NONSYN	622	624	GTC	811	813	ATC	49;48;48	A;T;C	49;48;48	.	MdtC is a transporter that forms a heteromultimer complex with MdtB to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex. In the absence of MdtB, MdtC can form a homomultimer complex that results in a functioning efflux complex with a narrower drug specificity.;mdtC
mdtC.3000794.U00096.2158385_2161463.257	mdtC.3000794.U00096.2158385_2161463.257	1	0	539	2480	mdtC	3078	3078	98.64	mdtC.l15.c17.ctg.1	3462	38.1	0	.	p	.	0	Q980H	NONSYN	2938	2940	CAA	3127	3129	CAC	8;8;8	C;A;C	8;8;8	.	MdtC is a transporter that forms a heteromultimer complex with MdtB to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex. In the absence of MdtB, MdtC can form a homomultimer complex that results in a functioning efflux complex with a narrower drug specificity.;mdtC
mdtC.3000794.U00096.2158385_2161463.257	mdtC.3000794.U00096.2158385_2161463.257	1	0	539	2480	mdtC	3078	3078	98.64	mdtC.l15.c17.ctg.1	3462	38.1	0	.	p	.	0	P981L	NONSYN	2941	2943	CCC	3130	3132	CTC	8;9;9	C;T;C	8;9;9	.	MdtC is a transporter that forms a heteromultimer complex with MdtB to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex. In the absence of MdtB, MdtC can form a homomultimer complex that results in a functioning efflux complex with a narrower drug specificity.;mdtC
mdtD.3001330.U00096.2161463_2162879.299	mdtD.3001330.U00096.2161463_2162879.299	1	0	539	1258	mdtD	1416	1416	98.38	mdtD.l15.c30.ctg.1	1916	34.9	0	.	p	.	0	D3E	NONSYN	7	9	GAT	186	188	GAA	30;31;31	G;A;A	30;31;31	.	mdtD;Efflux pump mdtD
mdtD.3001330.U00096.2161463_2162879.299	mdtD.3001330.U00096.2161463_2162879.299	1	0	539	1258	mdtD	1416	1416	98.38	mdtD.l15.c30.ctg.1	1916	34.9	0	.	p	.	0	T226A	NONSYN	676	678	ACG	855	857	GCG	40;41;40	G;C;G	40;41;40	.	mdtD;Efflux pump mdtD
mdtD.3001330.U00096.2161463_2162879.299	mdtD.3001330.U00096.2161463_2162879.299	1	0	539	1258	mdtD	1416	1416	98.38	mdtD.l15.c30.ctg.1	1916	34.9	0	.	p	.	0	V340I	NONSYN	1018	1020	GTC	1197	1199	ATC	37;36;38	A;T;C	36;36;37	.	mdtD;Efflux pump mdtD
mdtD.3001330.U00096.2161463_2162879.299	mdtD.3001330.U00096.2161463_2162879.299	1	0	539	1258	mdtD	1416	1416	98.38	mdtD.l15.c30.ctg.1	1916	34.9	0	.	p	.	0	L441F	NONSYN	1321	1323	TTG	1500	1502	TTT	52;51;52	T;T;T	52;50;52	.	mdtD;Efflux pump mdtD
mdtE.3000795.AP009048.3980025_3981183.753	mdtE.3000795.AP009048.3980025_3981183.753	1	0	27	1424	mdtE	1158	1158	99.31	mdtE.l15.c4.ctg.1	1653	45.8	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	mdtE;MdtE is the membrane fusion protein of the MdtEF multidrug efflux complex. It shares 70% sequence similarity with AcrA.
mdtF.3000796.U00096.3660413_3663527.286	mdtF.3000796.U00096.3660413_3663527.286	1	0	539	3332	mdtF	3114	3114	98.52	mdtF.l15.c4.ctg.1	3627	49.1	0	.	p	.	0	A295T	NONSYN	883	885	GCC	1133	1135	ACC	49;49;50	A;C,A;C	49;43,1;49	.	MdtF is the multidrug inner membrane transporter for the MdtEF-TolC efflux complex.;mdtF
mdtF.3000796.U00096.3660413_3663527.286	mdtF.3000796.U00096.3660413_3663527.286	1	0	539	3332	mdtF	3114	3114	98.52	mdtF.l15.c4.ctg.1	3627	49.1	0	.	p	.	0	N709D	NONSYN	2125	2127	AAT	2375	2377	GAC	50;52;51	G;A;C	49;51;50	.	MdtF is the multidrug inner membrane transporter for the MdtEF-TolC efflux complex.;mdtF
mdtG.3001329.NC_007779.1115840_1117067.599	mdtG.3001329.NC_007779.1115840_1117067.599	1	0	513	1232	mdtG	1227	1047	99.33	mdtG.l15.c30.ctg.1	1595	34.8	0	.	p	.	0	V200I	NONSYN	598	600	GTC	743	745	ATC	45;44;45	A;T;C	44;44;45	.	mdtG;Efflux protien mdtG.
mdtG.3001329.NC_007779.1115840_1117067.599	mdtG.3001329.NC_007779.1115840_1117067.599	1	0	513	1232	mdtG	1227	174	99.43	mdtG.l15.c30.ctg.2	482	15.5	0	.	p	.	0	E5G	NONSYN	13	15	GAA	5	7	GGA	7;8;9	G;G;A	7;8;9	.	mdtG;Efflux protien mdtG.
mdtH.3001216.U00096.1124117_1125326.120	mdtH.3001216.U00096.1124117_1125326.120	1	0	539	984	mdtH	1209	1209	98.18	mdtH.l15.c30.ctg.1	1670	31.4	0	.	p	.	0	G134C	NONSYN	400	402	GGT	657	659	TGT	41;41;41	T;G;T	41;41;41	.	mdtH;Multidrug resistance protein MdtH
mdtH.3001216.U00096.1124117_1125326.120	mdtH.3001216.U00096.1124117_1125326.120	1	0	539	984	mdtH	1209	1209	98.18	mdtH.l15.c30.ctg.1	1670	31.4	0	.	p	.	0	S324L	NONSYN	970	972	TCG	1227	1229	TTG	41;39;38	T;T;G	40;39;35	.	mdtH;Multidrug resistance protein MdtH
mdtH.3001216.U00096.1124117_1125326.120	mdtH.3001216.U00096.1124117_1125326.120	1	0	539	984	mdtH	1209	1209	98.18	mdtH.l15.c30.ctg.1	1670	31.4	0	.	p	.	0	A394T	NONSYN	1180	1182	GCG	1437	1439	ACG	13;13;13	A;C;G	13;13;12	.	mdtH;Multidrug resistance protein MdtH
mdtL.3001215.U00096.3891614_3892790.621	mdtL.3001215.U00096.3891614_3892790.621	1	0	539	1210	mdtL	1176	1176	98.38	mdtL.l6.c30.ctg.1	1813	35.7	0	.	p	.	0	A185S	NONSYN	553	555	GCC	872	874	TCC	53;57;57	T;C;C	50;56;56	.	mdtL;Multidrug resistance protein MdtL
mdtN.3003548.AP009048.4306556_4307588.3298	mdtN.3003548.AP009048.4306556_4307588.3298	1	0	539	906	mdtN	1032	1032	98.06	mdtN.l6.c30.ctg.1	1643	29.4	0	.	p	.	0	V119I	NONSYN	355	357	GTT	657	659	ATT	23;23;22	A;T;T	23;22;22	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride.;mdtN
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	1844	mdtO	2052	2052	98.1	mdtO.l15.c30.ctg.1	2399	40.6	0	.	p	.	0	V11M	NONSYN	31	33	GTG	201	203	ATG	29;29;29	A;T;G	29;29;29	.	mdtO;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	1844	mdtO	2052	2052	98.1	mdtO.l15.c30.ctg.1	2399	40.6	0	.	p	.	0	T33I	NONSYN	97	99	ACC	267	269	ATC	24;25;25	A;T;C	23;25;25	.	mdtO;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	1844	mdtO	2052	2052	98.1	mdtO.l15.c30.ctg.1	2399	40.6	0	.	p	.	0	C116R	NONSYN	346	348	TGC	516	518	CGC	49;48;46	C;G;C	49;48;45	.	mdtO;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	1844	mdtO	2052	2052	98.1	mdtO.l15.c30.ctg.1	2399	40.6	0	.	p	.	0	N238S	NONSYN	712	714	AAC	882	884	AGC	47;45;45	A;G;C	47;44;43	.	mdtO;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	1844	mdtO	2052	2052	98.1	mdtO.l15.c30.ctg.1	2399	40.6	0	.	p	.	0	M305V	NONSYN	913	915	ATG	1083	1085	GTG	33;33;34	G;T;G	32;32;33	.	mdtO;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	1844	mdtO	2052	2052	98.1	mdtO.l15.c30.ctg.1	2399	40.6	0	.	p	.	0	D326N	NONSYN	976	978	GAC	1146	1148	AAC	21;21;21	A;A;C	20;18;20	.	mdtO;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	1844	mdtO	2052	2052	98.1	mdtO.l15.c30.ctg.1	2399	40.6	0	.	p	.	0	A341V	NONSYN	1021	1023	GCC	1191	1193	GTC	51;50;52	G;T;C	50;49;51	.	mdtO;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	1844	mdtO	2052	2052	98.1	mdtO.l15.c30.ctg.1	2399	40.6	0	.	p	.	0	M351I	NONSYN	1051	1053	ATG	1221	1223	ATA	57;57;57	A;T;A	57;57;57	.	mdtO;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	1844	mdtO	2052	2052	98.1	mdtO.l15.c30.ctg.1	2399	40.6	0	.	p	.	0	A387S	NONSYN	1159	1161	GCT	1329	1331	TCT	42;42;42	T;C;T	42;42;42	.	mdtO;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	1844	mdtO	2052	2052	98.1	mdtO.l15.c30.ctg.1	2399	40.6	0	.	p	.	0	T516A	NONSYN	1546	1548	ACG	1716	1718	GCG	42;42;44	G;C;G	41;39;43	.	mdtO;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	1844	mdtO	2052	2052	98.1	mdtO.l15.c30.ctg.1	2399	40.6	0	.	p	.	0	L587I	NONSYN	1759	1761	CTT	1929	1931	ATC	39;40;40	A,G;T;C	38,1;40;40	.	mdtO;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	539	1196	mdtP	1467	1467	97.96	mdtP.l6.c30.ctg.1	1976	32.4	0	.	p	.	0	S129A	NONSYN	385	387	TCA	672	674	GCG	41;42;43	G;C;G	41;42;43	.	mdtP;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	539	1196	mdtP	1467	1467	97.96	mdtP.l6.c30.ctg.1	1976	32.4	0	.	p	.	0	A187T	NONSYN	559	561	GCC	846	848	ACC	28;29;30	A;C;C	28;29;30	.	mdtP;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	539	1196	mdtP	1467	1467	97.96	mdtP.l6.c30.ctg.1	1976	32.4	0	.	p	.	0	H211R	NONSYN	631	633	CAC	918	920	CGC	37;37;40	C,G;G;C	36,1;37;40	.	mdtP;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	539	1196	mdtP	1467	1467	97.96	mdtP.l6.c30.ctg.1	1976	32.4	0	.	p	.	0	V250A	NONSYN	748	750	GTT	1035	1037	GCT	36;38;38	G;C;T	35;37;37	.	mdtP;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	539	1196	mdtP	1467	1467	97.96	mdtP.l6.c30.ctg.1	1976	32.4	0	.	p	.	0	R278K	NONSYN	832	834	AGA	1119	1121	AAA	27;27;28	A;A;A	27;27;28	.	mdtP;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	539	1196	mdtP	1467	1467	97.96	mdtP.l6.c30.ctg.1	1976	32.4	0	.	p	.	0	Q284R	NONSYN	850	852	CAA	1137	1139	CGA	37;39;40	C;G;A	37;39;40	.	mdtP;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	539	1196	mdtP	1467	1467	97.96	mdtP.l6.c30.ctg.1	1976	32.4	0	.	p	.	0	S339A	NONSYN	1015	1017	TCC	1302	1304	GCC	31;31;32	G;C;C	31;31;31	.	mdtP;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	539	1196	mdtP	1467	1467	97.96	mdtP.l6.c30.ctg.1	1976	32.4	0	.	p	.	0	H343D	NONSYN	1027	1029	CAT	1314	1316	GAT	40;39;38	G;A;T	40;39;38	.	mdtP;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	539	1196	mdtP	1467	1467	97.96	mdtP.l6.c30.ctg.1	1976	32.4	0	.	p	.	0	G482A	NONSYN	1444	1446	GGT	1731	1733	GCT	21;19;20	G;C;T	21;18;17	.	mdtP;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mfd.3003844.NC_000913.3.1170517_1173964.3609	mfd.3003844.NC_000913.3.1170517_1173964.3609	1	0	539	3136	mfd	3447	3447	99.16	mfd.l15.c4.ctg.1	3863	43.3	0	.	p	.	0	T437K	NONSYN	1309	1311	ACG	1522	1524	AAG	29;30;29	A;A;G	28;28;28	.	mfd;mfd dissociates transcription elongation complexes blocked at nonpairing lesions and mediates recruitment of DNA repair proteins. The Mfd (mutation frequency decline) protein, also known as transcription-repair coupling factor, is responsible for ATP-dependent removal of stalled RNA polymerase from DNA lesions by inducing forward movement of the RNA polymerase and subsequent recruitment of nucleotide excision repair machinery to the sites of the lesions.
mfd.3003844.NC_000913.3.1170517_1173964.3609	mfd.3003844.NC_000913.3.1170517_1173964.3609	1	0	539	3136	mfd	3447	3447	99.16	mfd.l15.c4.ctg.1	3863	43.3	0	.	p	.	0	M796L	NONSYN	2386	2388	ATG	2599	2601	CTG	35;35;34	C;T;G	35;33;34	.	mfd;mfd dissociates transcription elongation complexes blocked at nonpairing lesions and mediates recruitment of DNA repair proteins. The Mfd (mutation frequency decline) protein, also known as transcription-repair coupling factor, is responsible for ATP-dependent removal of stalled RNA polymerase from DNA lesions by inducing forward movement of the RNA polymerase and subsequent recruitment of nucleotide excision repair machinery to the sites of the lesions.
mgrB.3003820.NC_000913.3.1908622_1908766.3586	mgrB.3003820.NC_000913.3.1908622_1908766.3586	1	0	27	172	mgrB	144	144	100.0	mgrB.l15.c4.ctg.2	166	28.0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	mgrB;mgrB is a small transmembrane protein produced in the PhoPQ signalling system. It acts as a negative regulator in this system. Inactivation or down-regulation of mgrB confers colistin resistance by absence as shown in Klebsiella pneumoniae
msbA.3003950.NC_000913.3.966620_968369.3754	msbA.3003950.NC_000913.3.966620_968369.3754	1	0	539	1852	msbA	1749	1749	98.68	msbA.l6.c4.ctg.1	2265	43.8	0	.	p	.	0	S278N	NONSYN	832	834	AGC	1079	1081	AAC	40;40;40	A;A;C	40;40;39	.	MsbA is a multidrug resistance transporter homolog from E. coli and belongs to a superfamily of transporters that contain an adenosine triphosphate (ATP) binding cassette (ABC) which is also called a nucleotide-binding domain (NBD). MsbA is a member of the MDR-ABC transporter group by sequence homology. MsbA transports lipid A, a major component of the bacterial outer cell membrane, and is the only bacterial ABC transporter that is essential for cell viability.;msbA
msbA.3003950.NC_000913.3.966620_968369.3754	msbA.3003950.NC_000913.3.966620_968369.3754	1	0	539	1852	msbA	1749	1749	98.68	msbA.l6.c4.ctg.1	2265	43.8	0	.	p	.	0	M460I	NONSYN	1378	1380	ATG	1625	1627	ATA	65;65;66	A;T;A	64;65;66	.	MsbA is a multidrug resistance transporter homolog from E. coli and belongs to a superfamily of transporters that contain an adenosine triphosphate (ATP) binding cassette (ABC) which is also called a nucleotide-binding domain (NBD). MsbA is a member of the MDR-ABC transporter group by sequence homology. MsbA transports lipid A, a major component of the bacterial outer cell membrane, and is the only bacterial ABC transporter that is essential for cell viability.;msbA
murA.3003775.CP009072.1414817_1416077.3548	murA.3003775.CP009072.1414817_1416077.3548	1	1	27	1246	murA_12	1260	1260	98.49	murA_12.l15.c4.ctg.1	1760	37.7	1	SNP	p	D369N	0	.	.	1105	1107	GAT	1359	1361	GAT	63;64;64	G;A,G;T	63;63,1;61	murA.3003775.CP009072.1414817_1416077.3548:1:1:D369N:.:murA or UDP-N-acetylglucosamine enolpyruvyl transferase catalyses the initial step in peptidoglycan biosynthesis and is inhibited by fosfomycin. Overexpression of murA through mutations such as Asp369Asn and Leu370Ile confers fosfomycin resistance. Extensive evidence has shown the significance of C115 mutations in conferring fosfomycin resistance since this residue represents a primary binding site for the antibiotic across many species.	Escherichia coli mutant murA conferring resistance to fosfomycin
murA.3003775.CP009072.1414817_1416077.3548	murA.3003775.CP009072.1414817_1416077.3548	1	1	27	1246	murA_12	1260	1260	98.49	murA_12.l15.c4.ctg.1	1760	37.7	1	SNP	p	L370I	0	.	.	1108	1110	CTG	1362	1364	CTG	62;62;59	C;T;G	62;61;58	murA.3003775.CP009072.1414817_1416077.3548:1:1:L370I:.:murA or UDP-N-acetylglucosamine enolpyruvyl transferase catalyses the initial step in peptidoglycan biosynthesis and is inhibited by fosfomycin. Overexpression of murA through mutations such as Asp369Asn and Leu370Ile confers fosfomycin resistance. Extensive evidence has shown the significance of C115 mutations in conferring fosfomycin resistance since this residue represents a primary binding site for the antibiotic across many species.	Escherichia coli mutant murA conferring resistance to fosfomycin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	528	414	nfsA	723	405	99.01	nfsA.l15.c4.ctg.1	936	23.3	0	.	p	.	0	R27C	NONSYN	79	81	CGT	321	323	TGT	26;27;28	T;G;T	26;26;28	.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	528	414	nfsA	723	405	99.01	nfsA.l15.c4.ctg.1	936	23.3	0	.	p	.	0	I117T	NONSYN	349	351	ATC	591	593	ACC	46;43;41	A;C;C	44;43;41	.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	528	414	nfsA	723	405	99.01	nfsA.l15.c4.ctg.1	936	23.3	1	SNP	p	R15C	0	.	.	43	45	CGC	285	287	CGC	51;48;44	C;G;C	51;47;44	nfsA.3003751.NC_000913.3.891183_891906.3520:1:1:R15C:.:nfsA encodes the major oxygen-insesitive nitroreductase in E. coli. The first step of resistance to nitrofurazone is mutation of nfsA.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	528	414	nfsA	723	405	99.01	nfsA.l15.c4.ctg.1	936	23.3	1	SNP	p	S33R	0	.	.	97	99	AGC	339	341	AGC	25;27;27	A;G;C	25;27;27	nfsA.3003751.NC_000913.3.891183_891906.3520:1:1:S33R:.:nfsA encodes the major oxygen-insesitive nitroreductase in E. coli. The first step of resistance to nitrofurazone is mutation of nfsA.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	528	414	nfsA	723	405	99.01	nfsA.l15.c4.ctg.1	936	23.3	1	SNP	p	G131D	0	.	.	391	393	GGC	633	635	GGC	24;23;23	G;G;C	24;23;21	nfsA.3003751.NC_000913.3.891183_891906.3520:1:1:G131D:.:nfsA encodes the major oxygen-insesitive nitroreductase in E. coli. The first step of resistance to nitrofurazone is mutation of nfsA.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
ompF.3003390.NC_007779.986315_987404.2075	ompF.3003390.NC_007779.986315_987404.2075	1	1	539	1336	ompF	1089	1089	99.91	ompF.l15.c30.ctg.1	1724	41.6	0	.	p	.	0	D312E	NONSYN	934	936	GAT	1218	1220	GAG	55;54;55	G;A;G	55;53;55	.	Escherichia coli ompF mutants
ompF.3003390.NC_007779.986315_987404.2075	ompF.3003390.NC_007779.986315_987404.2075	1	1	539	1336	ompF	1089	1089	99.91	ompF.l15.c30.ctg.1	1724	41.6	1	SNP	p	G141E	0	.	.	421	423	GGT	705	707	GGT	59;59;60	G;G;T	58;59;60	ompF.3003390.NC_007779.986315_987404.2075:1:1:G141E:.:Mutant forms of the Escherichia coli outer membrane porin OmpF result in reduced permeability to antibiotics.	Escherichia coli ompF mutants
ompF.3003390.NC_007779.986315_987404.2075	ompF.3003390.NC_007779.986315_987404.2075	1	1	539	1336	ompF	1089	1089	99.91	ompF.l15.c30.ctg.1	1724	41.6	1	SNP	p	G141D	0	.	.	421	423	GGT	705	707	GGT	59;59;60	G;G;T	58;59;60	ompF.3003390.NC_007779.986315_987404.2075:1:1:G141D:.:Mutant forms of the Escherichia coli outer membrane porin OmpF result in reduced permeability to antibiotics.	Escherichia coli ompF mutants
ompF.3003390.NC_007779.986315_987404.2075	ompF.3003390.NC_007779.986315_987404.2075	1	1	539	1336	ompF	1089	1089	99.91	ompF.l15.c30.ctg.1	1724	41.6	1	SNP	p	R154A	0	.	.	460	462	CGT	744	746	CGT	53;53;55	C;G;T	53;53;55	ompF.3003390.NC_007779.986315_987404.2075:1:1:R154A:.:Mutant forms of the Escherichia coli outer membrane porin OmpF result in reduced permeability to antibiotics.	Escherichia coli ompF mutants
ompF.3003390.NC_007779.986315_987404.2075	ompF.3003390.NC_007779.986315_987404.2075	1	1	539	1336	ompF	1089	1089	99.91	ompF.l15.c30.ctg.1	1724	41.6	1	SNP	p	R154D	0	.	.	460	462	CGT	744	746	CGT	53;53;55	C;G;T	53;53;55	ompF.3003390.NC_007779.986315_987404.2075:1:1:R154D:.:Mutant forms of the Escherichia coli outer membrane porin OmpF result in reduced permeability to antibiotics.	Escherichia coli ompF mutants
parC.3003941.NC_004337.2.3159154_3161413.3742	parC.3003941.NC_004337.2.3159154_3161413.3742	1	1	539	2378	parC_2	2259	2259	99.2	parC_2.l15.c30.ctg.1	2833	44.9	0	.	p	.	0	A533V	NONSYN	1597	1599	GCG	1910	1912	GTG	52;54;54	G;T;G,C	51;52;51,1	.	Shigella flexneri parC conferring resistance to fluoroquinolones
parC.3003941.NC_004337.2.3159154_3161413.3742	parC.3003941.NC_004337.2.3159154_3161413.3742	1	1	539	2378	parC_2	2259	2259	99.2	parC_2.l15.c30.ctg.1	2833	44.9	0	.	p	.	0	P542S	NONSYN	1624	1626	CCG	1937	1939	TCG	50;50;51	T;C;G	44;46;49	.	Shigella flexneri parC conferring resistance to fluoroquinolones
parC.3003941.NC_004337.2.3159154_3161413.3742	parC.3003941.NC_004337.2.3159154_3161413.3742	1	1	539	2378	parC_2	2259	2259	99.2	parC_2.l15.c30.ctg.1	2833	44.9	0	.	p	.	0	S747N	NONSYN	2239	2241	AGC	2552	2554	AAC	20;18;18	A;A;C	19;17;18	.	Shigella flexneri parC conferring resistance to fluoroquinolones
parC.3003941.NC_004337.2.3159154_3161413.3742	parC.3003941.NC_004337.2.3159154_3161413.3742	1	1	539	2378	parC_2	2259	2259	99.2	parC_2.l15.c30.ctg.1	2833	44.9	1	SNP	p	A85T	0	.	.	253	255	GCG	566	568	GCG	63;60;57	G;C;G,A	59;56;53,1	parC.3003941.NC_004337.2.3159154_3161413.3742:1:1:A85T:.:Point mutation in parC conferring resistance to fluoroquinolone antibiotics in Shigella flexneri,	Shigella flexneri parC conferring resistance to fluoroquinolones
parC.3003941.NC_004337.2.3159154_3161413.3742	parC.3003941.NC_004337.2.3159154_3161413.3742	1	1	539	2378	parC_2	2259	2259	99.2	parC_2.l15.c30.ctg.1	2833	44.9	1	SNP	p	D111H	0	.	.	331	333	GAT	644	646	GAT	57;57;56	G;A;T	57;57;55	parC.3003941.NC_004337.2.3159154_3161413.3742:1:1:D111H:.:Point mutation in parC conferring resistance to fluoroquinolone antibiotics in Shigella flexneri,	Shigella flexneri parC conferring resistance to fluoroquinolones
parC.3003941.NC_004337.2.3159154_3161413.3742	parC.3003941.NC_004337.2.3159154_3161413.3742	1	1	539	2378	parC_2	2259	2259	99.2	parC_2.l15.c30.ctg.1	2833	44.9	1	SNP	p	S129P	0	.	.	385	387	TCC	698	700	TCC	43;42;41	T;C;C	39;41;40	parC.3003941.NC_004337.2.3159154_3161413.3742:1:1:S129P:.:Point mutation in parC conferring resistance to fluoroquinolone antibiotics in Shigella flexneri,	Shigella flexneri parC conferring resistance to fluoroquinolones
parE.3003316.NC_007779.3172159_3174052.2073	parE.3003316.NC_007779.3172159_3174052.2073	1	1	539	1450	parE_1	1893	1893	97.52	parE_1.l15.c30.ctg.1	2429	31.8	0	.	p	.	0	D473N	NONSYN	1417	1419	GAC	1643	1645	AAC	32;32;35	A;A;C	32;32;35	.	Escherichia coli parE conferring resistance to fluoroquinolones
parE.3003316.NC_007779.3172159_3174052.2073	parE.3003316.NC_007779.3172159_3174052.2073	1	1	539	1450	parE_1	1893	1893	97.52	parE_1.l15.c30.ctg.1	2429	31.8	1	SNP	p	D476N	0	.	.	1426	1428	GAT	1652	1654	GAT	44;45;45	G;A;T	44;45;44	parE.3003316.NC_007779.3172159_3174052.2073:1:1:D476N:.:Point mutation in Escherichia coli parE resulting in fluoroquinolones resistance	Escherichia coli parE conferring resistance to fluoroquinolones
patA.3000024.NC_000913.3.3219493_3220873.3692	patA.3000024.NC_000913.3.3219493_3220873.3692	1	0	539	1542	patA	1380	1380	99.78	patA.l15.c30.ctg.1	1977	41.6	0	.	p	.	0	P202Q	NONSYN	604	606	CCG	906	908	CAG	43;43;47	C;A;G	43;43;47	.	patA;PatA is an ABC transporter of Streptococcus pneumoniae that interacts with PatB to confer fluoroquinolone resistance.
patA.3000024.NC_000913.3.3219493_3220873.3692	patA.3000024.NC_000913.3.3219493_3220873.3692	1	0	539	1542	patA	1380	1380	99.78	patA.l15.c30.ctg.1	1977	41.6	0	.	p	.	0	E360D	NONSYN	1078	1080	GAG	1380	1382	GAT	46;46;45	G;A;T	46;45;45	.	patA;PatA is an ABC transporter of Streptococcus pneumoniae that interacts with PatB to confer fluoroquinolone resistance.
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	4544	rpoB	4029	4029	99.03	rpoB.l15.c4.ctg.1	4615	52.6	1	SNP	p	V146F	0	.	.	436	438	GTT	736	738	GTT	57;57;59	G;T;T	56;56;58	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:V146F:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	4544	rpoB	4029	4029	99.03	rpoB.l15.c4.ctg.1	4615	52.6	1	SNP	p	Q513P	0	.	.	1537	1539	CAG	1837	1839	CAG	60;62;63	C;A;G	60;62;63	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:Q513P:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	4544	rpoB	4029	4029	99.03	rpoB.l15.c4.ctg.1	4615	52.6	1	SNP	p	Q513L	0	.	.	1537	1539	CAG	1837	1839	CAG	60;62;63	C;A;G	60;62;63	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:Q513L:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	4544	rpoB	4029	4029	99.03	rpoB.l15.c4.ctg.1	4615	52.6	1	SNP	p	H526Y	0	.	.	1576	1578	CAC	1876	1878	CAC	57;55;55	C;A;C	56;55;55	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:H526Y:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	4544	rpoB	4029	4029	99.03	rpoB.l15.c4.ctg.1	4615	52.6	1	SNP	p	R529C	0	.	.	1585	1587	CGT	1885	1887	CGT	49;50;51	C;G;T	48;50;51	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:R529C:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	4544	rpoB	4029	4029	99.03	rpoB.l15.c4.ctg.1	4615	52.6	1	SNP	p	R529S	0	.	.	1585	1587	CGT	1885	1887	CGT	49;50;51	C;G;T	48;50;51	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:R529S:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	4544	rpoB	4029	4029	99.03	rpoB.l15.c4.ctg.1	4615	52.6	1	SNP	p	S531F	0	.	.	1591	1593	TCC	1891	1893	TCC	50;48;46	T;C;C	50;47;46	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:S531F:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	4544	rpoB	4029	4029	99.03	rpoB.l15.c4.ctg.1	4615	52.6	1	SNP	p	L533P	0	.	.	1597	1599	CTC	1897	1899	CTC	40;40;41	C;T;C	40;40;39	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:L533P:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	4544	rpoB	4029	4029	99.03	rpoB.l15.c4.ctg.1	4615	52.6	1	SNP	p	T563P	0	.	.	1687	1689	ACC	1987	1989	ACC	62;63;63	A;C;C	62;63;63	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:T563P:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	4544	rpoB	4029	4029	99.03	rpoB.l15.c4.ctg.1	4615	52.6	1	SNP	p	P564L	0	.	.	1690	1692	CCT	1990	1992	CCT	61;63;61	C;C;T	61;63;61	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:P564L:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	4544	rpoB	4029	4029	99.03	rpoB.l15.c4.ctg.1	4615	52.6	1	SNP	p	R687H	0	.	.	2059	2061	CGT	2359	2361	CGT	97;97;97	C;G;T	97;97;96	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:R687H:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	12204	rrsB+	1542	998	99.9	rrsB+.l15.c17.ctg.1	1173	324.0	0	.	n	.	0	A226G	SNP	226	226	A	401	401	G	416	G	416	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	12204	rrsB+	1542	998	99.9	rrsB+.l15.c17.ctg.1	1173	324.0	1	SNP	n	A794T	0	.	.	794	794	A	969	969	A	339	A	331	rrsC.3003333.U00096.3941808_3943349.3229:0:0:A794T:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	12204	rrsB+	1542	998	99.9	rrsB+.l15.c17.ctg.1	1173	324.0	1	SNP	n	A794G	0	.	.	794	794	A	969	969	A	339	A	331	rrsC.3003333.U00096.3941808_3943349.3229:0:0:A794G:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	12204	rrsB+	1542	998	99.9	rrsB+.l15.c17.ctg.1	1173	324.0	1	SNP	n	G926A	0	.	.	926	926	G	1101	1101	G	378	G,C	372,1	rrsC.3003333.U00096.3941808_3943349.3229:0:0:G926A:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	12204	rrsB+	1542	998	99.9	rrsB+.l15.c17.ctg.1	1173	324.0	1	SNP	n	G926C	0	.	.	926	926	G	1101	1101	G	378	G,C	372,1	rrsC.3003333.U00096.3941808_3943349.3229:0:0:G926C:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	12204	rrsB+	1542	998	99.9	rrsB+.l15.c17.ctg.1	1173	324.0	1	SNP	n	G926T	0	.	.	926	926	G	1101	1101	G	378	G,C	372,1	rrsC.3003333.U00096.3941808_3943349.3229:0:0:G926T:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	12204	rrsB+	1542	998	99.9	rrsB+.l15.c17.ctg.1	1173	324.0	0	HET	.	.	.	C183T	.	183	183	C	358	358	C	333	C,T	233,99	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	12204	rrsB+	1542	998	99.9	rrsB+.l15.c17.ctg.1	1173	324.0	0	HET	.	.	.	T90C,A	.	90	90	T	265	265	T	343	T,C,A	243,94,1	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	12204	rrsB+	1542	998	99.9	rrsB+.l15.c17.ctg.1	1173	324.0	0	HET	.	.	.	A250T	.	250	250	A	425	425	A	363	A,T	262,98	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	12204	rrsB+	1542	998	99.9	rrsB+.l15.c17.ctg.1	1173	324.0	0	HET	.	.	.	G474A	.	474	474	G	649	649	G	406	G,A	291,108	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	12204	rrsB+	1542	998	99.9	rrsB+.l15.c17.ctg.1	1173	324.0	0	HET	.	.	.	A253T	.	253	253	A	428	428	A	361	A,T	259,96	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	12204	rrsB+	1542	998	99.9	rrsB+.l15.c17.ctg.1	1173	324.0	0	HET	.	.	.	C719T,G	.	719	719	C	894	894	C	319	C,T,G	198,120,1	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	12204	rrsB+	1542	998	99.9	rrsB+.l15.c17.ctg.1	1173	324.0	0	HET	.	.	.	C194T	.	194	194	C	369	369	C	350	C,T	272,72	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	12204	rrsB+	1542	998	99.9	rrsB+.l15.c17.ctg.1	1173	324.0	0	HET	.	.	.	A79G	.	79	79	A	254	254	A	358	A,G	253,100	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	12204	rrsB+	1542	998	99.9	rrsB+.l15.c17.ctg.1	1173	324.0	0	HET	.	.	.	T273A,G,C	.	273	273	T	448	448	T	356	T,A,G,C	247,94,1,1	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	12204	rrsB+	1542	517	100.0	rrsB+.l15.c17.ctg.2	561	384.8	1	SNP	n	A1519T	0	.	.	1519	1519	A	494	494	A	317	A	311	rrsC.3003333.U00096.3941808_3943349.3229:0:0:A1519T:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	12204	rrsB+	1542	517	100.0	rrsB+.l15.c17.ctg.2	561	384.8	1	SNP	n	A1519G	0	.	.	1519	1519	A	494	494	A	317	A	311	rrsC.3003333.U00096.3941808_3943349.3229:0:0:A1519G:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	12204	rrsB+	1542	517	100.0	rrsB+.l15.c17.ctg.2	561	384.8	1	SNP	n	A1519C	0	.	.	1519	1519	A	494	494	A	317	A	311	rrsC.3003333.U00096.3941808_3943349.3229:0:0:A1519C:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	12204	rrsB+	1542	517	100.0	rrsB+.l15.c17.ctg.2	561	384.8	0	HET	.	.	.	C1038T	.	1038	1038	C	13	13	C	212	C,T	68,37	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	12204	rrsB+	1542	127	100.0	rrsB+.l15.c17.ctg.4	127	75.1	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	12204	rrsB+	1542	127	95.31	rrsB+.l15.c17.ctg.6	127	53.2	0	.	n	.	0	G1002A	SNP	1002	1002	G	54	54	A	87	A,T	86,1	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	12204	rrsB+	1542	127	95.31	rrsB+.l15.c17.ctg.6	127	53.2	0	.	n	.	0	G1006C	SNP	1006	1006	G	58	58	C	87	C	87	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	12204	rrsB+	1542	127	95.31	rrsB+.l15.c17.ctg.6	127	53.2	0	.	n	.	0	T1010C	SNP	1010	1010	T	62	62	C	94	C	92	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	12204	rrsB+	1542	127	95.31	rrsB+.l15.c17.ctg.6	127	53.2	0	.	n	.	0	A1019.	DEL	1019	1019	A	70	70	G	83	G	83	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	12204	rrsB+	1542	127	95.31	rrsB+.l15.c17.ctg.6	127	53.2	0	.	n	.	0	.1023G	INS	1023	1023	T	75	75	G	80	G	80	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	12204	rrsB+	1542	127	95.31	rrsB+.l15.c17.ctg.6	127	53.2	0	HET	.	.	.	C1038T	.	1038	1038	C	90	90	C	55	C,T	0,55	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
sat_1.3002895.AB211124.0_525.584	sat_1.3002895.AB211124.0_525.584	1	0	27	750	sat_1	525	525	100.0	sat_1.l6.c4.ctg.1	1012	39.5	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	sat-1;sat-1 is a plasmid-mediated streptothricin acetyltransferase in Escherichia coli
soxR.3003381.U00096.4277468_4277933.2074	soxR.3003381.U00096.4277468_4277933.2074	1	1	27	526	soxR	465	465	100.0	soxR.l15.c4.ctg.1	914	30.8	1	SNP	p	R20H	0	.	.	58	60	CGC	241	243	CGC	49;49;50	C;G;C	49;49;50	soxR.3003381.U00096.4277468_4277933.2074:1:1:R20H:.:SoxR is a sensory protein that upregulates soxS expression in the presence of redox-cycling drugs. This stress response leads to the expression many multidrug efflux pumps.	Escherichia coli soxR mutants
soxR.3003381.U00096.4277468_4277933.2074	soxR.3003381.U00096.4277468_4277933.2074	1	1	27	526	soxR	465	465	100.0	soxR.l15.c4.ctg.1	914	30.8	1	SNP	p	G121D	0	.	.	361	363	GGT	544	546	GGT	48;47;47	G;G;T	48;46;47	soxR.3003381.U00096.4277468_4277933.2074:1:1:G121D:.:SoxR is a sensory protein that upregulates soxS expression in the presence of redox-cycling drugs. This stress response leads to the expression many multidrug efflux pumps.	Escherichia coli soxR mutants
soxS.3003511.NC_000913.4277059_4277383.3528	soxS.3003511.NC_000913.4277059_4277383.3528	1	1	27	438	soxS_1	324	324	99.69	soxS_1.l15.c4.ctg.1	897	26.1	1	SNP	p	A12S	0	.	.	34	36	GCA	336	338	GCA	48;51;53	G;C;A	48;51;53	soxS.3003511.NC_000913.4277059_4277383.3528:1:1:A12S:.:SoxS is a global regulator that up-regulates the expression of AcrAB efflux genes. It also reduces OmpF expression to decrease cell membrane permeability.	Escherichia coli soxS mutant
tolC.3000237.FJ768952.0_1488.563	tolC.3000237.FJ768952.0_1488.563	1	0	27	1620	tolC	1488	1488	98.72	tolC.l15.c4.ctg.1	2011	42.9	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	tolC;TolC is a protein subunit of many multidrug efflux complexes in Gram negative bacteria. It is an outer membrane efflux protein and is constitutively open. Regulation of efflux activity is often at its periplasmic entrance by other components of the efflux complex.
